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Abstract

The purpose of this study was to determine if a seven-day live high–train low
(LHTL) simulated altitude exposure could improve (a) anaerobic and/or aerobic capacity
(VO2peak) in trained cyclists (n = 10) and (b) VO2peak and/or 400m swimming performance
in collegiate swimmers (n=8).
In procedures approved by the EMU Human Subjects Review Board, cyclists
performed seven cycle ergometer trials to measure maximal mean power output
(MMPO4min), maximal accumulated oxygen deficit (MAOD), and VO2peak, whereas
swimmers completed five incremental arm ergometer trials (VO2peak) and 400m
swimming performance trials before and after LHTL. No significant changes were
observed in any measured parameter. Therefore, the conclusion of this study is that a 7day simulated altitude exposure of 2,500m for 8.5 hours each night is insufficient to
result in changes in MAOD, VO2peak, or performance among highly trained cyclists and
swimmers.
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Chapter I: Introduction
Athletes around the world train to perform optimally during competition. Some,
however, may have an edge over the competition due to where they live. Athletes who
live at high altitudes are exposed to a decreased barometric pressure in the atmosphere.
This decreased pressure makes the transfer of oxygen from the alveoli to the blood stream
more difficult, in return requiring the individual’s physiologic system to adapt and
become more efficient (Wilber, 2001). The physiologic adaptations of altitude exposure
feature enhanced erythropoiesis (increased oxygen carrying capacity), increased red
blood cell volume (RCV), and increased oxygen carrying capacity (VO2max; Bailey &
Davies, 1997; Levine & Stray-Gundersen, 1997), as well as improved muscle buffer
capacity and maximal accumulated oxygen deficit (MAOD; Gore, Clark, & Saunders,
2007; Gore, Hahn, Aughey, Martin, Ashenden, Clark, Garnham, Roberts, Slater, &
McKenna, 2001; Mizuno, Juel, Bro-Rasmussen, Mygrind, Schibye, Rasmussen, & Saltin,
1990; Roberts, Clark, Townsend, Anderson, Gore, & Hahn, 2003).
Although these adaptations can arise through altitude exposure, training at altitude
may result in a significant decrease in training intensity and thus athletic performance
(Gore, Little, Hahn, Rice, Bourdon, Lawrence, Walsh, Stanef, Barnes, Parisotto, Martin,
& Pyne, 1997; Squires & Buskirk, 1982). Therefore, debate about the tradeoff between
the “benefits” of altitude exposure and the limitations of a decreased training intensity
exist. In a benchmark study performed by Levine and Stray-Gunderson (1997), a “live
high–train low” (LHTL) approach was implemented over the classic “live high–train
high” (LHTH) approach also developed by Levine and Stray-Gunderson (1992). The
results of this study demonstrated a greater improvement in the LHTL group when

compared to the LHTH group, therefore suggesting that the LHTL approach elicits
greater adaptations to altitude exposure.
Due to the limited locations that would allow an individual to conveniently live at
altitude and train at sea level, the utilization of altitude tent systems have become more
prevalent in recent years (Baker & Hopkins, 1998). Altitude tents simulate a natural
altitude environment by adding nitrogen into the air, thus lowering the oxygen
concentration. This allows individuals to follow the LHTL approach in a convenient
manner.
Several studies have demonstrated proposed performance or physiologic
improvements after exposure to a simulated altitude; however, the mechanism behind the
adaptation is unclear (Wilber, 2001). Many studies (Chapman, Stray-Gundersen, &
Levine, 1998; Levine & Stray-Gundersen, 1997; Nummela & Rusko, 2000) have shown
that performance improvements after simulated altitude exposures are due to increases in
VO2max and therefore adaptations in aerobic metabolism. However, other studies have
revealed that adaptations to the simulated altitude exposure occur in the anaerobic energy
systems, with increased muscle buffer capacity and MAOD being reported after altitude
exposure (Mizuno et al., 1990; Roberts et al., 2003; Saltin, Kim, Terrados, Larsen,
Svedenhag, & Rolf, 1995). There is also uncertainty regarding the necessary level of
exposure (elevation and duration) to achieve optimal adaptation. Previous research has
suggested the duration of exposures to be upwards of 28 days (Gore et al., 1997; Levine
& Stray-Gundersen, 1997), which may seem impractical for some individuals. The
results indicated above, specifically the dramatic improvements in MAOD after a short
term altitude exposure found by Roberts et al. (2003), and the limited research regarding
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the potential anaerobic adaptations to short term altitude exposure have motivated this
study.

Statement of the Purpose
The purpose of this research was to determine if a short-term, seven-day
simulated LHTL altitude exposure could increase (a) anaerobic capacity, as assessed by
MAOD, and/or aerobic capacity in trained cyclists; and (b) aerobic capacity and/or 400meter swimming performance in highly trained swimmers.

Significance
Technology has continued to play a role in the development of sport performance
through the creation of simulated altitude training systems. This theory is founded on the
discoveries, led mostly by Levine and Stray-Gunderson (Reviewed in Wilber, 2001), that
highlight the effects of altitude exposure. The major manufacturers of these systems are
Hypoxico Altitude Training Systems (Hypoxico Inc., NY) and Colorado Altitude
Training Systems (Colorado Altitude Training, CO). The literature has focused primarily
on the aerobic adaptations associated with altitude exposure. However, other research
suggests that there may be a substantial anaerobic effect as a result of the simulated
altitude exposure.
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Research Questions
1. Can significant physiologic anaerobic improvements, specifically MAOD, and/or
aerobic capacity improvements occur in trained cyclists after a seven-day simulated
altitude exposure?
2. Does a short-term, seven-day simulated altitude exposure significantly improve
aerobic capacity and race performance in 400-meter swimming trials among highly
trained collegiate swimmers?

Assumptions
1. All participants will occupy the tent alone under simulated altitude conditions eight to
twelve hours per day for the duration of seven days.
2. All participants will appropriately and thoroughly document daily training in a
logbook that will be turned in to the researcher at the end of the study.
3. The altitude tent will accurately and consistently maintain the level of oxygen that
would be equivalent to a desired altitude of 2,500m.
4. The participants will follow all specific guidelines and recommendations given by the
researcher.

Limitations
1. There are a limited number of altitude tents available for use in this study, therefore
limiting the number of subjects tested.
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2. Due to the inability of all subjects to undergo the altitude exposure at the same time,
participants’ fitness levels may vary based on the point of season that the simulated
altitude exposure is completed.
3. Due to a limit of altitude tent systems, a single/double blind control group cannot be
part of this study’s protocol.

Delimitations
1. Participants will sleep in the altitude tent for a seven-day period.
2. Participants must reside in the tent for eight to twelve hours per day.
3. Participants will be members of the Eastern Michigan University Swim Team and the
local cycling community, ranging in age from 18 to 45 years.
4. Participants who have been exposed to an altitude greater than 2,000m for longer than
14 days in the past three months may be excluded from the study.

Definition of Terms
1. Simulated Altitude – Altitude tents, like those designed by Hypoxico Altitude
Training Systems and Colorado Altitude Training, allow individuals to sleep at a
simulated elevation and gain the benefits associated with altitude exposure. The tent
fits over an individual’s bed and is reasonably air tight, but allows room air to enter as
a safety precaution. An oxygen concentrator is used to pump lower percentage
oxygen air into the tent simulating a given altitude (2,500m in this case).
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2. Live High–Train Low (LHTL) – Individuals who spend a substantial portion (e.g. 8
hrs/day) at moderate elevations but train at lower elevations, preferably near sealevel.
3. Live High–Train High (LHTH) – Individuals who live and train at moderate
elevations (2,000-3,000m).
4. Live Low–Train Low (LLTL) – Individuals who live and train at elevations near sealevel.
5. Intermittent Altitude Exposure (IAE) – Generally speaking, individuals participating
in an IAE protocol will be exposed to altitude periodically and for relatively shorter
durations compared to constant exposure.
6. Hypoxia – an oxygen deficiency caused by a reduction in the partial pressure of
oxygen in ambient air because of a decrease in either the ambient barometric
pressures or the oxygen concentration of the inspired gas (Mazzeo & Fulco, 2006).
7. Erythropoiesis – The stimulation of erythrocytes, which allow for an increased ability
to transport and utilize oxygen within the body (Mack, 2006). Erythrocytes transport
the oxygen-carrying molecule hemoglobin from the lungs to the tissues. Exercise and
hypoxic conditions can increase the levels of erythrocytes in one’s body.
8. Maximal Oxygen Uptake (VO2max) – Maximum amount of oxygen utilized during
whole body dynamic exercise.
9. Peak Oxygen Uptake (VO2peak) – The greatest amount of oxygen uptake used by
small muscle mass (e.g. upper vs. lower body).
10. Maximal Accumulated Oxygen Deficit (MAOD) – Oxygen deficit is represented as
the area between the curve of the oxygen demand and the curve of the actual oxygen
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uptake and is representative of the anaerobic capacity (Medbo, Mohn, Tabata, Bahr,
Vaage, & Sejersted, 1988).
11. Na+ -K+ -ATPase – Maintains Na+ and K+ concentration gradients as well as
membrane excitability (Clausen, 2003; Fowles, Green, Tupling, O’Brien & Roy,
2002; Fraser, Li, Carey, Wang, Sangkabutra, Sostaric, Selig, Kjeldsen & McKenna,
2002), therefore maintaining the muscle membrane potential necessary for muscular
contraction.
12. Erythropoietin – a hormone that stimulates red blood cell production.
13. Hematocrit – component of blood that is composed of cells, mostly red blood cells.
14. Hemoglobin – a protein in red blood cells that is responsible for transporting oxygen
to tissues.
15. Red Blood Cells – contain hemoglobin for the transport of oxygen to the tissues.
16. Reticulocytes – immature cells that do not have all the characteristics of red blood
cells.
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Chapter II: Review of Literature
Introduction
For nearly half a century, scientists have known that altitude can have both a
detrimental and positive impact on sports performance (Levine, Stray-Gundersen, Gore,
& Hopkins, 2005). In an effort to achieve the potential performance adaptations, altitude
training has become a prominent component to seasonal training designs (Wilber, 2001)
in some athletes. However, research has been unable to provide a clear understanding as
to the mechanisms involved in adaptations to altitude exposure and the optimal training
design to result in the greatest benefits. This ambiguity has continued the progression in
simulated altitude research and has inspired scientists to attempt to uncover the mystery.

Approaches to Altitude Exposure
Increases in natural altitude coincide with a decreased barometric pressure. This
leads to progressive decreases in the partial pressure of inspired oxygen and, at some
point, the partial pressure of oxygen in arterial blood. According to Boyle’s Law, the
reduction in barometric pressure associated with increases in altitude results in an
increase in the volume of atmospheric gases, specifically nitrogen, oxygen, and carbon
dioxide (Mazzeo & Fulco, 2006). This makes the delivery of oxygen to the tissues more
difficult, resulting in either a necessary reduction in exercise intensity and/or physiologic
adaptations to account for this environmental change.
There are many methods to achieve an artificial altitude exposure without actually
traveling to a natural altitude environment. Some artificial methods simulate the actual
change in barometric pressure through the utilization of an airtight environment (e.g.
8

barometric pressure chambers). Alternatively, individuals can attain a similar response
by lowering the oxygen concentration of the inspired gas (e.g. altitude tent or house).
Regardless of the approach taken, the results are very similar. The focus of research is
now centered on determining the exposure approach that achieves the greatest adaptation.

Intermittent Altitude Exposure (IAE).
According to Levine (2002), intermittent altitude exposure is a method in which
individuals discontinuously expose themselves to hypoxic conditions attempting to
receive similar adaptations to that of natural altitude exposure, in effort to improve
athletic performance. The thought behind this approach is that a more severe exposure
will allow for adaptations to an altitude environment; however, the shorter durations will
not result in a detrimental decrease in performance. However, individuals who exercise
at altitude typically experience confounding results compared to individuals who follow a
LHTL approach or IAE approach without exercise.
In an attempt to better understand this approach, researchers asked six males and
females living at sea level to complete a cycle time trial both before and after a threeweek period of IAE (Beidleman, Muza, Fulco, Cymerman, Ditzler, Stulz, Staab,
Robinson, Skrinar, Lewis, & Sawka, 2003). The IAE consisted of four hours per day,
five days per week, over a three-week period, at an elevation of 4,300m. The protocol
had participants cycle for 45-60 minutes at an intensity of 60-70 percent VO2max during
each IAE session, followed by resting for the remainder of the exposure. The IAE
training approach improved time trial performance by 21 percent, adductor pollicis
endurance by 63 percent, and resting arterial O2 saturation at altitude by 10 percent.

9

Based on the results, these researchers argue that IAE training can yield similar benefits
and adaptations as chronic altitude residence.
Morton and Cable (2005) investigated whether IAE would enhance performance
to a greater degree than would equivalent sea level training. Sixteen moderately trained
males were split into treatment and control groups. Throughout a four-week period, the
participants performed 30 minutes of cycling exercises three times per week. The
treatment group completed the exercise at a simulated altitude of 2,750m, while the
control group completed the workouts at sea level. Researchers measured changes in
VO2max, blood lactate, anaerobic performance (e.g. power output), and hemoglobin and
hematocrit, but found no significant differences between groups. Therefore, it was
concluded that this IAE routine had no impact on aerobic or anaerobic performance,
possibly due to the fact that the treatment group exercised at altitude.
Researchers followed a Chilean Army’s long-term exposure to intermittent
hypoxia demonstrated by relocating from sea level to 3,550m every three and a half days
over a 22-year period of time (Heinicke, Prommer, Cajigal, Viola, Behn, & Schmidt,
2003). The soldiers’ hematological response to this change in altitude was analyzed and
resulted in an 11 percent increase in total hemoglobin mass and similar increases in red
cell volume and hematocrit. Based on these results, it was determined that
acclimatization to long-term IAE results in similarly elevated hemoglobin and red cell
volume responses to that of chronic hypoxic exposures.
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Live High–Train Low Approach.
In 1997, Levine and Stray-Gundersen performed one of the most notable altitude
studies that changed previous notions in regards to what was deemed the best way to
approach altitude exposures. Previously, researchers believed that individuals received
peak adaptation by following a LHTH approach (Levine & Stray-Gundersen, 1992).
However, the results from this groundbreaking research demonstrated more robust
adaptations. Therefore, Levine and Stray-Gunderson (1997, 2006) suggested living high,
which stimulates erythropoiesis and maximizes the oxygen transport adaptations
associated with altitude, and training low, which avoids a detraining effect with the
necessary decrease in intensity at altitude as well as any detrimental effects of altitude
(e.g. altitude sickness).
Therefore, Levine and Stray-Gundersen (1997) set out to uncover the mystery
about the physiologic differences to a variety of altitude exposure approaches.
Participants were divided into one of three natural altitude groups: (a) LHTL - live at
2,500m and train at 1,200-1,400m, (b) LHTH - live at 2,500m and train at 2,500m, or (c)
LLTL - live at sea level (150m) and train at sea level (150m). All three groups were
exposed to similar training regimens to control for training adaptations, and all groups
were exposed to an environment with similar terrain. After the four-week exposure to
this approach, the group that demonstrated the most robust improvement was the LHTL
group, who had an increase in VO2max as well as race performance.
Another study sought to compare the difference between a LHTL and LLTL
regimen among participants (Schmitt, Millet, Robach, Nicolet, Brugniaux, Fouillot, &
Richalet, 2006). The LHTL participants were exposed to simulated altitudes of 2,500m,
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3,000m, and 3,500m and completed training sessions at 1,200m. Alternatively, LLTL
participants remained at a constant elevation of 1,200m throughout the study’s duration.
Results demonstrated an increase in VO2max in both the LHTL and LLTL groups,
although the groups were not significantly different. However, peak power tended to
increase more in the LHTL group than the LLTL group (4.1 percent vs. 1.9 percent,
respectively, p=0.06). Based on these results, researchers agreed that the best approach
to altitude exposure is by following the LHTL approach.
A similar LHTL approach exposed participants to simulated altitudes of 2,500m,
3,000m, and 3,500m for 11 hours per day and trained at an altitude of 1,200m. Results
from this LHTL approach found a variety of blood parameters demonstrating significant
improvements up to the elevation of 3,000m when compared to the pre-test values
(Robach, Schmitt, Brugniaux, Nicolet, Duvallet, Fouillot, Montereau, Lasne, Pialoux,
Olsen, & Richalet, 2006a). Despite these adaptations in the participant’s blood
composition, VO2max and time to exhaustion resulted in no improvement from pre- to
post-test for the two groups.
The same researchers (Robach, Schmitt, Brugniaux, Roels, Millet, Hellard,
Nicolet, Duvallet, Fouillot, Montereau, Lasne, Pialoux, Olsen, & Richalet, 2006b) also
followed a LHTL approach almost identical to that just mentioned by Robach et al.
(2006a). Red blood cell volume increased only in the LHTL group, and their VO2max
tended to increase to a greater amount than in controls. Therefore, authors concluded that
improvements in blood parameters do not always lead to improvements in VO2max and
performance.
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The literature indicates that the best approach to altitude training is to follow a
LHTL technique (Baker & Hopkins, 1998; Levine, 2002; Levine & Stray-Gundersen,
1997, 2006). This enables the individual to gain the benefits from altitude exposure and
yet train at elevations that facilitate intensities necessary to improve or maintain fitness
and thus performance. Intermittent hypoxic exposures occur for shorter durations, which
may be convenient; however, this is likely outweighed by the severe levels of hypoxia
that may result in negative reactions (e.g. altitude sickness) by participants.

Optimal Exposure of Altitude
Research over the past decade has provided supporting evidence that a LHTL
approach results in the most robust performance enhancements. However, still debated
by researchers are the levels of altitude and duration of exposures that result in the
greatest adaptations (Hahn, Gore, Martin, Ashenden, Roberts, & Logan, 2001; Rusko,
1996). An altitude too great may result in detrimental effects (e.g. detraining and/or
altitude sickness), whereas one too low may not allow for adaptations to occur (Levine &
Stray-Gundersen, 1992, 1997). A variety of elevations have been found to result in
adaptations: 2,200m (Nummela & Rusko, 2000), 2,500m (Levine & Stray-Gundersen,
1997; Ri-Li, Witkowski, Zhang, Alfrey, Sivieri, Karlsen, Resaland, Harber, StrayGundersen, & Levine, 2002), and 3,000m (Brugniaux, Schmitt, Robach, Jeanvoine,
Zimmermann, Nicolet, Duvallet, Fouillot, & Richalet, 2006; Gore et al., 2001; Robach et
al., 2006a). In addition to the optimal elevation, researchers must also determine the
appropriate duration of exposure to result in adequate adaptations. Research has
indicated improvement in 5 to 7 days (Ashenden, Gore, Dobson, Boston, Parisotto,
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Emslie, Trout, & Hahn, 2000; Koistinen, Rusko, Irjala, Rajamaki, Penttinen, Sarparanta,
Karpakka, & Leppaluoto, 2000; Roberts, Clark, Townsend, Anderson, Gore, & Hahn,
2003), 14 days (Levine & Stray-Gundersen, 1997; Mizuno et al., 1990), or more than 27
days (Gore et al., 1997; Stray-Gundersen, Chapman, & Levine, 2001).

Elevation of Simulated Altitude.
Levine and Stray-Gundersen (1997) created a longitudinal research design to
study the effect of LHTL on performance. Recruited were 27 male and 12 female
competitive distance runners, aged 18 to 31 years. Participants performed a six-week
“lead-in” phase near sea level where the training was supervised, and familiarization
trials took place to assess baseline fitness. Participants were then divided into one of
three natural altitude groups: (a) LTHL [live at 2,500m and train at 1,200-1,400m], (b)
LHTH [live at 2,500m and train at 2,500m], or (c) LLTL [live at sea level (150m) and
train at sea level (150m)]. After a four-week period, the LHTH group experienced
similar adaptations in red blood cell volume and VO2max while living and training at
2,500m as did the LHTL group while living at 2,500m and training at 1,250m. The
difference between the two was an improvement in 5,000m time trial only seen in the
LHTL group. Therefore, it was concluded that exposure to a moderate altitude (e.g.
2,500m), combined with training at low altitude, is adequate to elicit 5,000m running
performance improvements.
Ten Swiss national team orienteers were paired with a control group and followed
a LHTL routine by living at 2,500m for 18 hours per day and training at 1,800m and
1,000m above sea level for 24 days (Wehrlin, Zuest, Hallen, & Marti, 2006). The
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hypoxic group showed increases in hemoglobin mass (5.3 percent, p<0.01) and red cell
volume (5 percent, p<0.01) compared to the control group, which showed no change.
These changes coincided with improvements in VO2max (4.1 percent, p< 0.05), time to
exhaustion (41 seconds, p<0.05), and 5,000m running times (18 seconds, p<0.05).
Therefore, the researchers concluded that significant improvements, particularly
hemoglobin mass and red cell volume, were made by living at 2,500m and training
between 1,000 and 1,800m.
Ri-Li and colleagues (2002) investigated the impact of a variety of altitudes on
the stimulation of erythropoietin release. Over a four-week duration, participants were
exposed to altitudes of 1,780m, 2,085m, 2,454m, and 2,800m for a period of 24 hours.
Researchers measured erythropoietin levels at sea-level and after 6 and 24 hours at each
altitude. It was reported that erythropoietin increased significantly by 24-30 percent
(p<0.05) after 6 hours of exposure at all altitudes. However, erythropoietin experienced
increases of approximately 77-92 percent at the altitudes of 2,454m and 2,800m, which
continued to increase after 24 hours. These results allowed researchers to conclude that
the threshold altitude for stimulating sustained erythropoietin release is 2,100-2,500m.
Below this altitude, the erythropoietic response is minimal and not sustained for long
periods of time.
The rate of erythropoiesis, arguably a primary mechanism for performance
improvement (Levine & Stray-Gundersen, 1997), is dependent upon the severity of
altitude (Ri-Li et al., 2002). This would suggest that the greater the altitude, the greater
the adaptation in erythropoiesis. However, some researchers believe that altitudes above
3,500m would result in detrimental effects, such as altitude sickness (Montgomery, Luce,
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Michael & Mills, 1989). Therefore, a group of researchers designed a LHTL study to
evaluate the effects of varying altitude on a group of swimmers, cross-country skiers, and
runners (Brugniaux, Schmitt, Robach, Jeanvoine, Zimmermann, Nicolet, Duvallet,
Fouillot, & Richalet, 2006). Cross-country skiers were exposed to 2,500, 3,000, and
3,500m for 11 hours per night and six nights at each altitude. Swimmers spent
approximately 16 hours per day at altitude, with five nights at 2,500m and eight nights at
3,000m. Runners were exposed to altitude 14 hours per day, with six nights at 2,500m
and twelve nights at 3,000m. Athletes exposed to 3,500m demonstrated no performance
improvement, no improvement in VO2max, and declines in overnight oxygen saturation.
Alternatively, participants below 3,500m experienced improvements in these measures.
Therefore, it was concluded that a LHTL exposure should not exceed 3,000m for a period
of 18 days, with at least 12 hours per day exposure.
As discussed in the opening section regarding LHTL (Robach et al., 2006a),
adaptations ceased beyond exposure of 3,000m. Participants were exposed to 2,500m,
3,000m, and 3,500m for 11 hours per day, for six days at each altitude, while training at
1,200m. A variety of blood parameters demonstrated significant improvements up to
3,000m but either declined or stayed the same after the exposure was increased to
3,500m.
Furthermore, Robach et al. (2006b - discussed in the LHTL section) exposed
swimmers to a 13-day LHTL protocol. Participants spent 16 hours per day at 2,500m for
five days and at 3,000m for eight days while performing their training at 1,200m. This
exposure failed to result in performance improvements; however, blood parameters were
affected.
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Participants trained at 1,200m while living at simulated altitudes of 2,500m for
five to eight days and then between 3,000m and 3,500m for eight to twelve days, as was
presented in the LHTL section (Schmitt et al., 2006). Results determined no significant
increase in VO2max between the LHTL and LLTL groups, whereas peak power tended to
increase more in the LHTL group than the LLTL group (4.1 vs. 1.9 percent, respectively,
p=0.06).

Duration at Simulated Altitude.
Contrary to a generalized belief that 14 days is the minimum duration needed at
simulated altitude to elicit adaptations (Levine & Stray-Gundersen, 1997, 2006), others
have discovered improvements after much shorter durations (Ashenden et al., 2000;
Koistinen et al., 2000; Roberts et al., 2003). Subjects followed a seven-day continuous
(24 hours per day) or intermittent (12 hours per day) simulated altitude exposure protocol
at 2,500m (Koistinen et al., 2000). Both the continuous and intermittent groups resulted
in 78 and 71 percent increases (p<0.05) in serum EPO levels, respectively. Due to the
similarities in results, it was concluded that exposures beyond 12 hours per day may have
no added impact on erythropoietin levels.
Likewise, six well-trained middle-distance runners spent 8-11 hours per night for
five nights in a simulated altitude tent at 2,650m (Ashenden et al., 2000). Five squad
members undertook the same training as a control group, which was conducted near sea
level (600m). For both groups, this five-night protocol occurred on three different
occasions, with a three-night interim between successive exposures. Venous blood
samples were measured for serum erythropoietin. The well-trained runners experienced
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significant improvements in serum erythropoietin (57 percent, p< 0.01) levels above
baseline values compared with the control group, whose erythropoietin levels did not
change. However, the increase in serum erythropoietin was insufficient to stimulate
reticulocyte production. It was concluded that when daily training loads are controlled,
the increases in serum erythropoietin known to occur following brief (e.g. 5-day)
exposure to a simulated altitude of 2,650m are insufficient to stimulate reticulocyte
production.
In an effort to determine if short-term simulated altitude was enough to elicit
performance adaptations, specifically those achieved through anaerobic sources,
researchers (Roberts et al., 2003) had participants undergo LHTL exposures of 5, 10, or
15 days. A total of 19 participants underwent testing on a cycle ergometer to measure
MAOD (as described by Medbo et al., 1988). Participants were assigned to a LHTL
simulated altitude exposure of 5, 10, or 15 nights at 2,650m for eight to ten hours each
night. Adaptations were discovered in their study, both aerobic and anaerobic in nature.
It was concluded, based on the results, that there was no difference in adaptation between
the 5, 10, or 15 day exposure.
Stray-Gundersen, Chapman, and Levine (2001) completed a study using 22
individuals who followed a LHTL protocol by living at 2,500m while performing high
intensity training at 1,250m for 27 days. This resulted in significant increases in
erythropoietin of nearly 100 percent (8.5 ± 0.05 to 16.2 ± 1.0 IU/ml), VO2max by 3
percent, and 3,000m running performance times of 1.1 percent. Based on these findings,
and in accordance with their previous findings, researchers concluded that 27 days of
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living high and maintaining high intensity training at lower altitudes is effective to
achieve physiologic adaptations that can improve performance.
Based on a review of previously published research (Wilber, Stray-Gundersen, &
Levine, 2007), it was concluded that the optimal exposure of altitude must consist of
2,000-2,500m (1,780m may not be high enough to stimulate erythropoiesis; alternatively,
2,800m produced no additional stimulus in erythropoiesis and potentially resulted in a
decreased performance) for a minimum of 12 hours per day, for 21 to 28 days.

Performance Evaluation
Many researchers (Reviewed in Wilber, 2001) agree that exposure to altitude
results in adaptations that lead to performance improvements. This has been
demonstrated in numerous scientific studies that expose participants to a variety of
previously described exposure parameters. What is not agreed upon is the mechanism
responsible for these adaptations. Some researchers feel the adaptation is aerobic (Levine
& Stray-Gundersen, 1997; Schmitt et al., 2006), anaerobic (Gore et al., 2001; Mizuno et
al., 1990; Roberts, 2003), or even the result of a placebo effect (Baker & Hopkins, 1998;
Clark, Hopkins, Hawley, & Burke, 2000). Therefore, further research is needed to better
understand the physiologic changes that occur as a result of altitude.

Aerobic.
The physiologic adaptations to altitude exposure have been shown to be similar to
those of athletic training alone (Hoppeler & Vogt, 2001). Levine and Stray-Gundersen
(1992, 1997, 2006) are highly convinced that the main mechanism for performance
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improvements after altitude exposure is the result of stimulation of erythropoiesis, which
has the potential to lead to increased production of red blood cells in the bone marrow,
and can, with time, improve an individual’s aerobic capacity and thus performance
potential. Increases in erythropoietin and red cell mass have been observed with several
hours of sleep exposure to altitude (Gore, Rodreguez, Truijens, Townsend, StrayGundersen, & Levine, 2006; Hoppeler & Vogt, 2001). Therefore, the utilization of
altitude exposure in an athlete’s training scheme may prove to be beneficial to
performance.
In 1997, Levine and Stray-Gundersen found that LHTH and LHTL subjects
demonstrated increased erythropoietin secretion, increased red blood cell volume by 9
percent (p<0.01), and VO2max improvements of 5 percent (p<0.05). However, 5,000m
time trial improvements of 1.3 percent (p<0.05) were seen only in the LHTL group.
These increases were found despite equivalent training between all groups, which
supports the conclusion that the altitude exposure was the reason for adaptation.
Therefore, it was concluded that a LHTL protocol is capable of eliciting more significant
5,000m running performance improvements.
One year later, Chapman, Stray-Gundersen & Levine (1998) retrospectively
studied the results to better understand potential individual variability in response to
altitude exposure. Based on the runners’ 5,000m running performance pre- and postaltitude, researchers divided the group into responders and non-responders. The main
stimulus for adaptation appeared to be demonstrated by altitude responders (52 percent)
who had a greater release of erythropoietin 30 hours after altitude exposure than did the
non-responders (34 percent), and this trend continued for the duration of the 28-day
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period. The participants who experienced this greater increase of erythropoietin also
demonstrated greater increases in the other measures. For example, responders resulted
in a 6 percent (p<0.05) improvement in VO2max, compared to non-responders who
experienced no change. Finally, 5,000m run performance times in the responders
significantly improved by 37 seconds (p<0.05), whereas the non-responder’s
performance time was 14 seconds slower.
As previously mentioned, Brugniaux et al. (2006) examined the optimal exposure
of altitude to elicit the best adaptation. Participants were exposed to varying altitudes of
2,500m, 3,000m, and 3,500m, for 11 to 16 hours per night, and for 5 to 12 nights at each
altitude. The athletes demonstrated a lack of improvement in performance beyond
3,500m as well as poor acclimatization. Mean nocturnal oxygen saturation (SaO2)
declined to as low as 90 percent at 3,500m and showed no improvement with
acclimatization. Conversely, the lower elevations experienced an initial decrease in SaO2
but later demonstrated normalization with acclimatization. The swimmers and runners
who did not go above altitudes of 3,000m experienced a VO2max increase of 8.1 percent
(p=0.09) and 7.1 percent (p<0.05), respectively. Conversely, the cross-country skiers
demonstrated no change in VO2max. Therefore, it was concluded that a LHTL exposure
should not exceed 3,000m for a period of 18 days, with at least 12 hours per day
exposure.
Mentioned previously were two similar studies to determine the optimal
adaptation after exposure to two different altitudes (Robach et al., 2006a; Robach, et al.,
2006b). In both studies, participants were exposed to altitudes of 2,500m, 3,000m, and
3,500m for varying lengths of time while training occurred at 1,200m in all instances.
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The Nordic skiers experienced significant improvements in hematocrit (2.3 percent,
p<0.05), hemoglobin (0.3 percent, p<0.05), red blood cell count (.2 percent, p<0.05), and
serum EPO (2.2 percent, p<0.05) up to 3,000m, but either declined or stayed the same
after the exposure was increased to 3,500m (Robach et al., 2006a). The LHTL swimmers
significantly improved red blood cell volume (8.5 percent, p=0.03); and VO2max tended to
increase (8.1 percent, p=0.09) to a greater amount than in controls (2.5 percent, p=0.21;
Robach et al., 2006b). Swimming performance trials of 2,000m were unchanged with
LHTL. The results demonstrate that altitudes greater than 3,000m serve no extra benefit
to individuals participating in a LHTL protocol and that an improvement in blood
parameters, specifically erythropoietin, does not always coincide with an improvement in
VO2max and performance.

Anaerobic.
As previously stated, Levine and Stray-Gundersen (2005) have suggested the
main mechanism for increases in sea-level performance after an altitude exposure are the
result of improved aerobic metabolism. However, the same authors (1997) stated that the
correlation between changes in VO2max versus the change in red blood cell volume
yielded a modest r2 = 0.137. According to Gore, Clark, and Saunders (2007), 86 percent
of the variance in VO2max could be derived from sources other than red blood cell
volume. This demonstrates that more than VO2max alone determines performance ability
(di Prampero, 1986).
Adenosine triphosphate (ATP) is the body’s main source of energy to perform
work (Medbo et al., 1988). ATP can be created aerobically and anaerobically, depending
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on the energy demands of the body. An individual’s anaerobic capacity can be
determined through a method of properly identifying maximal accumulated oxygen
deficit (MAOD; Medbo et al., 1988). Oxygen deficit is represented as the area between
the curve of the oxygen demand and the curve of the actual oxygen uptake and represents
the maximal amount of ATP formed by anaerobic processes during exercise. Therefore,
proper quantification of MAOD allows for researchers to understand any physiologic
changes occurring in anaerobic capacity.
As mentioned previously, Roberts et al. (2003) exposed participants to LHTL
exposures of 5, 10, or 15 days to assess changes in anaerobic capacity. No significant
difference in Maximal Mean Power Output in four minutes (MMPO4min), VO2max, or
MAOD were found when comparing the 5, 10, or 15 day exposures separately. However,
when the exposure durations were pooled together, significant improvements in the
following parameters were demonstrated. The LHTL athletes demonstrated a 3.7 percent
(p<0.05) increase in MMPO4min and a 9.6 percent (p<0.05) increase in MAOD from preto post-test. Both the LHTL and control group demonstrated small yet significant
improvements in VO2max after exposure, but were not significantly different between
groups. These authors concluded that a short-term exposure to simulated altitude, such as
5, 10, or 15 days, was enough to stimulate significant improvements in individual’s
anaerobic capacity.
In addition, some athletes have improved their efficiency after altitude exposure
(Hahn et al., 2001). Therefore, performance benefits are possibly the result of increased
anaerobic capacity or a greater efficiency of aerobic metabolism. These participants
demonstrated significant increases in erythropoietin of 80 percent (p<0.05) after one to
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five nights at a moderate altitude exposure. However, this increase in erythropoietin was
not enough to stimulate erythrocyte production over the participants’ 11 to 23 night
exposure to 2,650-3,000m, likely because erythropoietin values were no longer
significant at the end of the exposure. Thus, there is a demonstration of an anaerobic
improvement because VO2max tended to decrease (p=0.07) in the LHTL group but not in
controls; however, a four-minute supramaximal performance showed slight, nonsignificant improvements (1 ± 0.4 percent) after the exposure.
Nearly all systems of the body have mechanisms in place to regulate
physiological functions in order to maintain homeostasis. During exercise, lactate levels
have been known to increase in association with increases of hydrogen ions (H+) in the
cell, thus impacting the pH of the cell (Clark, Aughey, Gore, Hahn, Townsend, Kinsman,
Chow, McKenna, & Hawley, 2004). Regarding muscle pH, the Na+/H+ exchanger is
responsible for this maintenance of homeostasis at rest (Juel, Grunnet, Holse, Kenworthy,
Sommer & Wulff, 2001). As exercise intensity increases, monocarboxylate transporters
MCT1 and MCT4 are responsible for the transport of lactate in the muscle by coupling
this with the transport of H+ in a 1:1 ratio (Juel & Halestrap, 1999; Juel, 1996). MCT4
transporters are primarily located in glycolytic fibers and are believed to have a major
role in lactate removal (Juel & Halestrap, 1999). Therefore, improvements in the
appearance of MCT1 and MCT4 may have the ability to maintain appropriate levels of
pH and lactate within the body.
To better understand the anaerobic adaptations after altitude exposure, researchers
investigated monocarboxylate transporters MCT1 and MCT4, lactate kinetics, and
muscle buffering capacity (Clark et al., 2004). Therefore, 29 participants were exposed
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to 20 nights of continuous, intermittent (four 5 night blocks of exposure), or control
treatments. The simulated altitude was equivalent to 2,650m, and individuals were
exposed to 9-10 hours of this treatment nightly. After this exposure, all participants
including controls exhibited improvement in VO2peak as well as peak power output
(p<0.05). Lactate kinetics were significantly altered (p<0.05) after the continuous LHTL
exposure, which was demonstrated by decreased plasma lactate concentration at 85
percent VO2max as well as an increase in workload at 4 mmol/L lactate. However, there
were no differences among the groups in regard to muscle buffer capacity or MCT1 and
MCT4 abundance. Therefore, researchers concluded that this particular 20-night
exposure was successful at delaying blood lactate accumulation but did not alter lactate
metabolism or pH regulation. The explanation for this was left to further investigation.
High intensity exercise may result in pH decreases from about 7.1 to 6.5. This
can negatively impact muscle performance due to low pH inhibiting functions within the
muscle cell. Muscle buffer capacity, or the ratio of lactate accumulation and observed
change in muscle H+, may improve with training, potentially attributed to an individual’s
increased ability to slow lactate accumulation by improving lactate removal from the
muscle tissue as a result of increased level of monocarboxylate transporters MCT1 and
MCT4 (Aagaard & Bangsbo, 2006; Gore, Clark, & Saunders, 2007). This improvement
has also been demonstrated after a LHTL-simulated altitude exposure (Gore et al., 2001).
The LHTL group spent 23 nights at a simulated altitude of 3,000m, for 9.5 hours each
night. The control group experienced the location’s natural altitude of 600m for the
entire study. Participants demonstrated a significant 7 percent reduction in VO2peak after
LHTL, whereas the control group experienced no change. This occurred without any
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significant change in the work performed throughout the cycle ergometer testing, which
may allude to an increased efficiency. Furthermore, muscle buffer capacity increased
significantly in the LHTL group (17.7 ± 4.9 percent) but was unchanged in the control.
Finally, blood lactate levels did not increase significantly due to the LHTL exposure;
however, values were significantly different between the LHTL and control groups preand post-exposure (15.4 ± 3.3 mmol/L vs. 17.4 ± 1.2 mmol/L pre- vs. 17.3 ± 2.6 mmol/L
vs. 22.4 ± 1.7 mmol/L post-exposure, respectively). Therefore, these researchers
concluded that the increase in muscle buffer capacity may be indicative of an improved
mechanical efficiency.
Ten cross-country skiers were studied during a 14-day exposure to altitude where
participants stayed at 2,100m and trained at 2,700m (Mizuno et al., 1990). After this
treatment, researchers noticed no improvement in VO2max, whereas increases were seen in
oxygen deficit (MAOD; 29%, p<0.05) as well as short-term running performance (17%,
p<0.05). Muscle biopsies of the gastrocnemius and triceps brachii demonstrated a 6
percent improvement in muscle buffer capacity (p<0.05). These researchers found the
improvement in muscle buffering capacity of interest because both muscle groups
demonstrated similar changes, regardless of the differences in use specific to crosscountry skiing. Therefore, this study supports the results for anaerobic adaptations from
altitude exposure over the previously emphasized aerobic improvements.
Nummela and Rusko (2000) explored anaerobic adaptations occurring after a 10day simulated altitude exposure of 2,200m for 16 to 17 hours per day on male and female
400m sprinters. After the simulated altitude exposure, researchers found a one percent
(p<0.05) improvement in 400m times. These athletes also performed a maximal
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anaerobic run test, which consisted of a variable number of 20-second runs with 100
seconds of recovery until volitional exhaustion occurred. Participants were able to run
significantly faster at given lactate concentrations, which demonstrated an improvement
in anaerobic capacity (Nummela, Alberts, Rijntjes, Luhtanen, & Rusko, 1996; Nummela,
Mero, Stray-Gundersen, & Rusko, 1996). The researchers speculated that this adaptation
may have been the result of an improvement in muscle buffering capacity. This can be
supported by a significantly higher resting blood pH (p<0.05) in the altitude exposed
athletes than in the control group.
Retrospective analysis of 2,147 college-aged cadets was performed throughout
their time attending the U.S. Air Force Academy (USAFA) at an altitude of 2,210m
(Brothers, Wilber & Byrnes, 2007). All participants were sea-level residents prior to
their move to the USAFA complex. The cadets completed several tests to assess fitness,
the most noteworthy being an aerobic 1.5 mile run test and a series of testing stations to
identify anaerobic physical fitness. After two years of residence at 2,210m, the aerobic
1.5 run test improved significantly by 8.6 percent (p<0.002) over a sea-level control
group. Additionally, the levels of anaerobic physical fitness significantly improved in the
altitude exposed group by 6.8 percent (p<0.01). Brothers et al. (2007) concluded that
moderate altitude can result in significant hematological adaptations; however, this may
take up to seven months. Additionally, both aerobic and anaerobic adaptations may
occur as a result of this exposure.
The enzyme Na+ -K+ -ATPase is primarily located in the sarcolemma and plays an
important role in maintaining Na+ and K+ concentration gradients as well as membrane
excitability (Clausen, 2003; Fowles, Green, Tupling, O’Brien & Roy, 2002; Fraser, Li,
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Carey, Wang, Sangkabutra, Sostaric, Selig, Kjeldsen & McKenna, 2002). The primary
importance of Na+ -K+ -ATPase is that it maintains the muscle membrane potential
necessary for muscular contraction. It has been previously demonstrated that exposures
to altitude often result in Na+ -K+ -ATPase downregulation, as expressed by the near 14
percent reduction in Na+ -K+ -ATPase experienced by six mountain climbers who took a
21-day expedition to the top of Mount McKinley (6,194m; Green, Roy, Grant, Burnett,
Tupling, Otto, Pipe & McKenzie, 2000).
In order to better understand the Na+ -K+ -ATPase response to altitude,
participants were exposed to a simulated altitude of 3,000m for approximately 9.5 hours
each night for 23 nights while their training occurred at a natural altitude of 600m
(Aughey, Gore, Hahn, Garnham, Clark, Peterson, Roberts & McKenna, 2005). Muscle
biopsies were performed in order to realize changes in Na+ -K+ -ATPase enzyme
activity. After this exposure, LHTL participants resulted in a 7.2 ± 4.1 percent (p<0.05)
reduction in VO2max with no change in the control group. This reduction in VO2max,
however, did not result in any difference in total work between groups. There was also a
small but significant 2.9 percent (p<0.05) reduction in muscle maximal Na+ -K+ -ATPase
activity, but there was no corresponding decrease in this measure’s content, performance,
or plasma K+ regulation. This is important because it suggests that the LHTL altitude
exposure prevented the expected suppression of Na+ -K+ -ATPase due to altitude.
Therefore, they concluded that exposures such as this one might allow athletes to
minimize or completely avoid detrimental impacts on Na+ -K+ -ATPase, yet still benefit
from other potential physiologic adaptations from altitude exposure.
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The research provided above demonstrates that there are numerous physiologic
adaptations that can occur as a result of altitude exposure. These adaptations include
changes in EPO, VO2max, muscle buffer capacity, MAOD, performance, and more.
However, it is extremely difficult, and in many cases impractical, to measure all of these
parameters in one study. Therefore, researchers are presented with a great challenge to
identify the complete mechanism behind the adaptation.
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Chapter III: Methods
Introduction
Inclusion Criteria and Sample Recruitment
Eastern Michigan University’s College of Health and Human Services Human
Subjects Review Board approved this study prior to implementation. All participants
were required to provide medical clearance for maximal exercise and simulated altitude
exposure of 2,500m either by presenting a doctor’s note or through the EMU Athletics
Department mandatory physical assessment of athletes. Participants were recruited by
word of mouth and flyers posted throughout the cycling and swimming community.
Participants randomly served in both altitude and control conditions in order to
account for potential training adaptations. The study followed a cross-over design;
therefore, participants changed treatments after completion of the first assigned treatment.
If the altitude treatment was performed first, there was a three-week pause in data
collection before completing any testing as a control to allow any adaptation to
“washout.”
The following tests were performed to analyze any potential adaptations resulting
from the study design. All participants completed the tests to the best of their ability and
followed the instructions of the researchers. Researchers required that any workouts
completed the day before testing sessions remain easy and that participants consume a
consistent diet prior to all testing sessions. Also, in effort to maintain proper circadian
rhythm (Riley & Down, 1992), testing sessions were scheduled at similar times of day for
individual participants.
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Due to the swimmers’ training and competition schedule, data collection was
divided into two components (swimmers and cyclists) to allow for timely measurement of
the parameters involved. This design eliminated the confounding factors of competition
preparation (e.g. tapers, shaving, etc) and enabled researchers to structure workouts to
accommodate laboratory testing.

Part I: Maximal Accumulated Oxygen Deficit Adaptations
Description of Sample
Eight trained male cyclists ranging in age from 19 to 42 years participated in this
study. The average age was 29 ± 7.5 years, height 181 ± 2.9 cm, mass 75.3 ± 4.7 kg, and
training volume of 10.2 ± 1.4 hours per week.
Procedure
On seven separate occasions, participants came to the Exercise Physiology
Laboratory at Eastern Michigan University. Participants began the study by completing a
familiarization Maximal Mean Power Output in four minutes (MMPO4min) test on a
Velotron (Racermate, WA) electronically braked cycle ergometer (Figure 1). The
purpose of the familiarization trial was to reduce the possibility for learning
improvements. A second MMPO4min test was performed to confirm the results from the
familiarization trial. The values from these tests were used to determine appropriate
workloads in subsequent tests. This is relevant because a four-minute performance trial
would rely largely on aerobic metabolism; however, it is expected there is a significant
anaerobic contribution that needs to be considered (Medbo et al., 1988). Additionally,
this time frame is a common duration in international competitions for swimming, track,

31

and cycling (Craig, Norton, Bourdon, Wollford, Stanef, Squires, Olds, Conyers & Walsh,
1993; Spencer & Gastin, 2001) and is sufficient to exhaust anaerobic metabolism.
Testing for Maximal Accumulated Oxygen Deficit (MAOD) occurred
immediately prior to the start of the simulated altitude exposure. Participants slept alone
in a Hypoxico Altitude Tent System (Hypoxico Inc., NY) that simulated an altitude of
2,500m. The concentration of oxygen was measured using a Handi (Maxtec, UT)
handheld oxygen sensor. Participants were instructed to occupy the tent for eight to
twelve hours each day for a seven-day period. Immediately concluding the simulated
altitude exposure, participants performed a final MAOD test to realize any adaptations.
Throughout the duration of the study, participants documented training sessions in a
logbook provided to them.

Testing Measures
Maximal Mean Power Output in four Minutes (MMPO4min).
The first two tests completed were MMPO4min tests as recommended by Roberts
and colleagues (2003). Participants used a Velotron cycle ergometer to complete this
test. The ergometer was sized according to each individual’s preference, and these
settings were recorded. Before beginning the MMPO4min test, a ten-minute warm-up at a
maximal limit of 200 Watts (W) was performed. The participant then performed a fourminute all-out effort to determine maximal mean power output and maximal oxygen
uptake (VO2peak). Participants’ VO2peak was determined as the greatest 30-second average
of oxygen consumption at any point during the test. Participants were required to pedal
between the cadences of 90 to 110 revolutions per minute. The data from this test were
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then used to calculate workloads for future MAOD testing sessions. Blood lactates were
analyzed immediately before and after the MMPO4min test using LactatePro (Arkray,
Japan) handheld lactate analyzers.
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Figure 1. Velotron Cycle Ergometer
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Maximal Accumulated Oxygen Deficit (MAOD).
The remaining testing sessions were identical and measured participants’
anaerobic capacity. This was achieved by following a MAOD protocol (Roberts et al.,
2003) on a Velotron cycle ergometer. Participants began the test by completing a fourminute warm up at 25 percent of MMPO4min. This was followed by an incremental test
with three intervals lasting six minutes each at 50, 62.5, and 75 percent of MMPO4min.
After each six-minute interval there was a four-minute rest, consisting of two minutes
active rest at 25 percent of MMPO4min followed by two minutes seated passive rest. After
the final four-minute resting period, an MMPO4min was administered. Blood lactates
were analyzed immediately before and after the MAOD test using LactatePro handheld
lactate analyzers.
The determination of MAOD was calculated utilizing an Excel spreadsheet
(Microsoft, WA). First, the actual oxygen consumption during the MMPO4min test was
determined for each 15-second segment throughout the 4-minute trial. This value was
compared to the calculated oxygen consumption based on extrapolation of the
relationship of oxygen consumption between the three submaximal stages, and the
difference was reported. This 15-second calculated difference was then added throughout
the 4-minute effort, unless there was a segment that did not incur an oxygen deficit, in
which case that segment was not added to the total. This determination of MAOD was
compared to an alternative global method where any positive oxygen deficits were not
excluded from the overall result and no significant differences were found (results not
shown).
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Table 1
Cyclist’s study design

MMPO4min

Familiarization

Trial 1

x

x

MAOD
Lactate

x

x

Trial 2

Trial 3

x

x

x

x

x

Altitude Tent In

x

Altitude Tent Out
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Part II: Aerobic and Swimming Performance Adaptations
Description of Sample
Ten highly trained male swimmers from Eastern Michigan University’s Swim
Team, ranging in age from 19-21 years, participated in this study. The average age was
20 ± 0.6 years, height 185 ± 5.0 cm, and mass 80.8 ± 3.9 kg.

Procedure
On nine separate occasions, participants came to the campus of Eastern Michigan
University. Swimming trials occurred in the Jones Natatorium, and laboratory testing
occurred in a laboratory. The laboratory testing sessions consisted of VO2peak tests on a
SciFit Arm Ergometer (SciFit, OK; Figure 2), completing a ramp protocol to volitional
exhaustion. Bar-Or and Zwiren (1975) found that the arm ergometer had excellent
reproducibility and validity. The first test served as a familiarization trial to reduce the
possibility for learning improvements as well as to ensure valid determination of the
participant’s peak power output (PPO) and VO2peak. The participants performed a 400meter time trial swim performance one day before completing the baseline VO2peak test.
Participants then slept alone in a Hypoxico Altitude Tent System that simulated an
altitude of 2,500m. As the same for the cyclists, the concentration of oxygen was
analyzed each night using a Handi oxygen sensor. Participants were instructed to occupy
the tent for eight to twelve hours each day for a seven-day period. After six nights in the
simulated altitude tent, a 400-meter swim trial was performed. After seven nights,
VO2peak was re-evaluated to test for adaptations. Blood lactates were analyzed
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immediately before and after the VO2peak test and swim trial using LactatePro handheld
lactate analyzers.

Testing Measures
Peak oxygen consumption (VO2peak).
The first test was a VO2peak test and was completed on a SciFit Arm Ergometer.
The test began with a four-minute warm-up at 15 W. Next, the participant performed a
ramp protocol starting at 50 W for two minutes; followed by 10 W increases in workload
every two minutes until volitional exhaustion occurred. This test resulted in VO2peak and
Peak Power Output (PPO) values. The PPO was determined to be the lowest workload
completed to establish VO2 plateau.
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Figure 2. SciFit Pro II Arm Ergometer
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Swimming Trials.
Race performances were assessed once each week at the Jones Natatorium with a
timed 400 long-course meter swim. A standardized warm-up was developed for all
swimmers to complete before the swim trial, which consisted of an 800-meter choice,
600-meter kick/drill/swim alternating every 50 meters, and a 400-meter drill/build by 50
meters. Participants were started three to four minutes apart with no more than two
swimmers per lane to eliminate racing strategies and other uncontrollable factors. Blood
lactates were analyzed before warm-up and immediately after the race performance,
using a LactatePro hand held lactate analyzer.
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Table 2
Swimmer’s study design

VO2peak

Familiarization

Trial 2

Trial 3

x

x

x

x

x

x

x

400-meter Performance
Lactate

x

x

Altitude Tent In

x

Altitude Tent Out

41

Common Procedures for Testing Cyclists and Swimmers
VO2peak Measurement
A Jaeger Oxycon Mobile Metabolic Cart (Cardinal Health, CA; Figure 3) was
used to collect expired gases. This consisted of a facemask attached to a small unit worn
by the participant during exercise. This device measured the oxygen and carbon dioxide
inhaled and expired, respectively. As mentioned previously, VO2peak was defined as the
greatest 30-second average of oxygen consumption at any point during the test. Heart
rates were monitored with a Polar (Polar Electro, Finland) heart rate monitor.

42

Figure 3. Jaeger Oxycon Mobile Metabolic Cart

43

Blood Lactate Analysis
Each participant’s blood lactate concentration was measured in duplicate form
before and after each test throughout the study. This involved a small finger prick to
allow for the blood sample. This was achieved by using LactatePro (Arkray, Japan)
handheld analyzers.

Simulated Altitude
Hypoxico Altitude Tent Specifications: The HYP100 Hypoxic Generator (Figure
4) can produce airflow up to 5400 L/h and can simulate 0 – 6,400m. The tent’s (Figure
5) dimensions were 55cm H x 27cm W x 58cm D and the generator weighed 25 kg
(Hypoxico Inc., NY). The simulated altitude exposure occurred in the participant’s home
and was supervised by an adult whom they deemed responsible to monitor their safety
and well-being. The tent was either set up by the principal investigator or its assembly
was explained in detail. The Hypoxico generator’s flow volume was set to approximately
90 percent to achieve an oxygen percentage of approximately 15.42 percent, which
simulated the appropriate altitude of 2,500m (according to manufacturer’s instructions).
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Figure 4. HYP100 Hypoxic Generator
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Image 5. Hypoxic Altitude Tent
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Logbook
Participants maintained a detailed workout logbook throughout the duration of the
study. It included daily recordings of workout distance or duration, perceived difficulty,
modality of training, and maximal heart rate (HR). Also included was information about
the simulated altitude exposure, such as hours of sleep, quality of sleep, resting HR, and
verification of the O2 percentage inside the tent. Any additional comments the participant
felt pertinent and necessary were encouraged to be included in the logbook. The
questions regarding perceived workout difficulty and quality of sleep were ranked on a 110 scale. For example, workout difficulty was defined as 1 being the lightest workout
possible and 10 being the most vigorous. Sleep quality was defined as 1 being the worst
sleep quality and 10 being the best.

Data Analysis
All values are reported as mean ± standard deviation. Results were analyzed
using SPSS software version 15.0 (SPSS Inc, IL). A Multivariate Analysis of Variance
(MANOVA) was used to analyze differences by time and treatment in cyclists for:
VO2peak, MAOD, resting lactate, post lactate, and power output. The MANOVA was
used in swimmers for race time, VO2peak, power output, resting lactate, post lactate, and
time to exhaustion. Significance values were set at Alpha = 0.05.
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Chapter IV: Results
As stipulated in the Methods, there were two groups of athletes participating in
this study, and the results will be presented separately in this section.

Cyclists
Subject Characteristics
Eight trained male cyclists were included in the present study (Table 3). All
participants were required to be competitive cyclists for at least 2 years, train a minimum
of 8 hours per week, and be between the ages of 18 and 45.
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Table 3
Cyclist characteristics

Subjects
Parameter
Age (yrs)
Height (cm)
Weight (kg)
VO2peak (ml/kg/min)
Power (Watts)

Value
29.3
7.55
181.4
2.92
75.3
4.77
57.5
5.2
356
35

Mean values represented in first row with the standard deviation below.
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Attrition
Due to a malfunction in the metabolic analysis, one participant’s altitude trial had
to be removed from the data analysis. During the MMPO4min portion of the posttreatment MAOD test, the metabolic cart’s sample line became occluded and was not
able to collect accurate measures of VO2.
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Table 4
Physiologic results during cycle ergometer tests

Cyclists
Parameter
VO2peak (ml/min)
VO2peak (ml/min)
MAOD (ml/min)
MAOD (ml/min)
Resting Lactate (mmol/L)
Resting Lactate (mmol/L)
Post Lactate (mmol/L)
Post Lactate (mmol/L)
Power (Watts)
Power (Watts)

Trial 2
4588.38
517.68
4287.86
311.29
3992.75
1486.38
3735.29
930.49
2.13
1.42
1.37
0.36
13.99
1.87
13.81
1.80
353.88
30.55
351.29
42.89

Trial 3
4639.13 *
464.20
4295.57 *
369.85
4190.88
919.23
4223.86
1094.87
1.26
0.39
1.45
0.40
13.40
2.10
13.98
2.10
354.63
34.62
359.86
34.6

Control treatment in white; altitude treatment in gray. Mean values represented in first
row with the standard deviation below. * = treatment effect ≤ 0.05.
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Peak Oxygen Consumption
There were no significant differences found between trials; however, there was a
significant difference (p≤0.05) between groups where the control group expressed higher
VO2peak values (Table 4). It is also visible that the MMPO4min trial resulted in a nonsignificantly lower VO2peak in both groups.

Maximal Accumulated Oxygen Deficit
There were no significant differences demonstrated in MAOD between groups;
however, the difference in MAOD between Trial 2 and 3 was non-significantly greater in
the altitude group (3735 ± 930.5 vs. 4224 ± 1094.8 ml, respectively) than the control
group (3992 ± 1486.3 vs. 4190 ± 919.8 ml, respectively; Figure 6).
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Figure 6. MAOD differences between groups and trials
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Research Question 1:
Can significant physiologic anaerobic improvements, specifically MAOD, and/or aerobic
capacity improvements occur in trained cyclists after a seven-day simulated altitude
exposure?
Using a MANOVA to compare the dependent variables MAOD and VO2peak
through a treatment by trial analysis, the results demonstrated no significant improvement
in either parameter among the trained cyclists in the present study (p=0.730 and p=0.892,
respectively).

Lactate
There appeared to be a trend (p=0.12) for a treatment by trial interaction in resting
lactate values. Resting lactate concentrations in the control group decreased to a greater
extent from Trial 2 to 3 (2.13 ± 1.4 vs. 1.26 ± 0.39 mmol/L, respectively) than in the
altitude group (1.37 ± 0.36 vs. 1.45 ± 0.41 mmol/L, respectively).
Post lactate concentrations were not significantly different in either the altitude or
control group.

Power
There were no significant differences in power output between treatment groups.
However, the altitude group resulted in a greater, non-significant, improvement in power
output between Trials 2 and 3 (351 ± 42.89 vs. 359 ± 34.60 W, respectively). This is
compared to the control group’s power output that was unchanged between Trials 2 and 3
(353 ± 30.55 vs. 354 ± 34.62 W, respectively).
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Logbooks
There were no significant differences in any of the parameters identified by the
workout logbooks (difficulty, duration, and maximal heart rate) between the altitude and
control group (Table 5).
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Table 5
Cyclist’s workout logbooks

Daily Workouts
Parameter
Difficulty
Difficulty
Duration (mins)
Duration (mins)
Max HR
Max HR

Value
6.05
2.03
5.88
1.86
91.34
60.40
86.45
54.17
162
20.58
165
18.49

Control treatment in white; altitude treatment in gray. Mean values represented in first
row with the standard deviation below.
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Simulated Altitude Exposure
The altitude group’s sleep patterns were the only ones analyzed, and the groups
demonstrated a daily trend (p=0.086) in improved quality of sleep as the altitude
exposure progressed over the 7-day period. No other parameters expressed differences
between them by day.
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Table 6
Cyclist’s simulated altitude exposure

Altitude
Exposure
Parameter

Value

O2% In

16.06
0.51

O2% Out

15.54
0.50
56
5.92
52
6.54
8.54
1.11
7.80
1.12
6.40
1.83

HR In
HR Out
Hours Exposure
Hours Sleep
Sleep Quality

Mean values represented in first row with the standard deviation below.
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Swimmers
Subject Characteristics
Ten highly trained male swimmers from Eastern Michigan University’s Swim
Team ranging in age from 19-21 years participated in this study (Table 7).
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Table 7
Swimmer characteristics

Subjects
Parameter
Age (yrs)
Height (cm)
Weight (kg)
VO2peak (ml/min)
Power (Watts)
400-meter Time (m:ss.ms)

Value
20.30
0.67
185.6
5.03
80.8
3.97
42.6
4.90
139
25.13
4:47.67
00:10.50

Mean values represented in first row with the standard deviation below.
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Attrition
There was one instance where a participant was unable to finish the testing for the
control trials due to unforeseen and unavoidable circumstances. Therefore, this
participant’s control trials were not included in the data analysis.
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Table 8
Physiologic results during arm ergometer tests

Arm Ergometer Tests
Parameter
VO2peak (ml/min)
VO2peak (ml/min)
Resting Lactate (mmol/L)
Resting Lactate (mmol/L)
Post Lactate (mmol/L)
Post Lactate (mmol/L)
Power (Watts)
Power (Watts)
TTE (minutes)
TTE (minutes)

Trial 1

Trial 2

Trial 3

3379.00

3301.67

3417.67

563.21

379.16

490.14

3671.80

3471.80

3541.50

363.79

383.22

371.93

1.76

1.75

1.73

0.65

0.42

0.42

1.92

1.74

1.60

0.14

0.79

0.35

9.66

8.03

9.53

1.37

1.23

2.20

10.53

9.42

9.10

4.07

2.02

1.64

112.00

141.00

138.00

38.62

24.21

23.15

152.00

138.00

147.00

23.87

23.47

20.57

19.85

24.59

24.50

8.23

5.12

4.52

26.65

23.90

25.90

4.63

4.70

4.16

Control treatment in white; altitude treatment in gray. Means represented in first row
with the standard deviation below. Trial 1 = Familiarization, Trial 2 = Pre; Trial 3 =
Post.
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Table 9
Performance results from the 400-meter swim trials

Performance Tests
Parameter
Time (m:ss.ms)
Time (m:ss.ms)
Resting Lactate (mmol/L)
Resting Lactate (mmol/L)
Post Lactate (mmol/L)
Post Lactate (mmol/L)

Trial 1
4:51.45
0:13.29
4:48.08
0:10.03
1.72
0.56
2.00
0.81
10.46
1.66
11.21
1.70

Trial 2
4:46.33
0:08.90
4:45.07
0:09.86
1.82
0.49
1.99
0.77
10.82
1.15
11.05
1.76

Control treatment in white; altitude treatment in gray. Means represented in first row
with the standard deviation below. Trial 1 = Pre; Trial 2 = Post.
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Peak Oxygen Consumption
No significant differences in VO2peak were found between altitude and control
groups (Table 8). However, it appears that the altitude group experienced a trend in
treatment effect (p=0.139) with elevated VO2peak when compared to the control group.
Additionally, the control group resulted in a non-significantly greater improvement from
Trial 2 to 3 (3301.67 ± 379.16 vs. 3417.67 ± 490.14 ml/min, respectively) than the
altitude group (3471.80 ± 383.22 vs. 3541.50 ± 371.93 ml/min, respectively).

Swim Performance Time
The results conclude that there was no significant difference in 400-meter
performance time between treatment groups (Table 9). The altitude group reported faster
overall times than the control group; however, the control group non-significantly
improved more from Trial 1 to 2 (4:51.45 ± 00:13.29 vs. 4:46.33 ± 00:08.90 minutes,
respectively) than did the altitude group (4:48.08 ± 00:10.03 to 4:45.07 ± 00:09.86
minutes, respectively; Figure 7). There was individual variation in 400-meter
performance time between trials in both the control and altitude group (Figure 8 & 9,
respectively).
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Figure 7. 400-meter performance time differences between groups and trials
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Figure 8. Control performance results between trials as individuals
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Figure 9. Altitude performance results between trials as individuals
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Research Question 2:
Does a short-term seven-day simulated altitude exposure significantly improve aerobic
capacity and race performance in 400-meter swimming trials among highly trained
collegiate swimmers?
Using a MANOVA to compare the dependent variables VO2peak and 400-meter
swimming performance through a treatment by trial analysis, the statistical analysis
resulted in no significant improvement in either parameter among the swimmers in the
present study (p=0.883 and p=0.761, respectively).

Lactate
There were no significant differences in resting lactate values between groups
when completing the laboratory ergometer sessions. However, the altitude group
demonstrated a slight non-significant reduction in resting lactate between Trials 1, 2, and
3 (1.92 ± .14 vs. 1.74 ± .79 vs. 1.60 ± .35 mmol/L, respectively), whereas the control
group’s resting lactate concentration stayed essentially the same (1.73 ± .65 vs. 1.75 ± .42
vs. 1.73 ± .42 mmol/L, respectively). Post-lactate concentrations after the laboratory
ergometer sessions were not significantly different in either the altitude or control group.
The 400-meter swimming performance trials resulted in no significant difference
in resting or post-lactate concentration between groups (Table 9). However, the control
group experienced a slight non-significant increase in resting lactate concentration from
Trial 1 to 2 (1.72 ± 0.56 vs. 1.82 ± 0.49 mmol/L, respectively), whereas the altitude
group demonstrated no change in resting lactate concentration from Trial 1 to 2 (2.00 ±
0.81 vs. 1.99 ± 0.77 mmol/L, respectively). Likewise, post lactate concentrations
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experienced no significant changes between trials. The altitude group experienced a
slight reduction in post-lactate concentration from Trial 1 to 2 (11.21 ± 1.70 vs. 11.05 ±
1.76 mmol/L, respectively); conversely, the control group experienced slight increases in
post-lactate concentration from Trial 1 to 2 (10.46 ± 1.66 vs. 10.82 ± 1.15 mmol/L,
respectively).

Power
Demonstration of a greater power output capability by the altitude group over the
control group resulted in a trend (p=0.058; Table 8). Furthermore, a trend in treatment by
trial interaction (p=0.112; Table 8) was shown through the altitude group’s ability to
produce a greater amount of power from Trial 2 to 3 (138 ± 23.47 vs. 147 ± 20.57 W,
respectively) when compared to the control group (141 ± 24.21 vs. 138 ± 23.15 W,
respectively).

Time to Exhaustion
Results indicate a moderate trend in treatment by trial interaction (p=0.193; Table
8), allowing the altitude group to have a greater time to exhaustion between Trials 2 and
3 (23.90 ± 4.70 vs. 25.90 ± 4.16 minutes, respectively) compared to the control group
(24.59 ± 5.12 vs. 24.50 ± 4.52 minutes, respectively). There was also a treatment effect
(p=0.114; Table 8) experienced by the altitude group who had a greater overall time to
exhaustion (25.25 ± 4.44 minutes) than their control counterparts (23.69 ± 5.56 minutes).
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Logbooks
Based on the perceived difficulty of practices by the swimmers, there was no
significant difference between groups. Likewise, there were no significant differences in
maximal heart rate between groups during any of the workout days. However,
differences were found within workout distance between the altitude and control groups.
A significant treatment effect (p=0.043; Table 10) was shown where the control group
swam a greater distance during workouts than the altitude group. Also, a trend was
visible for a treatment by day interaction (p=0.132) for workout distance.
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Table 10
Swimmer’s workout logbooks

Daily Workouts
Parameter
Difficulty
Difficulty
Distance (meters)
Distance (meters)
Max HR (bpm)
Max HR (bpm)

Value
6.91
1.41
6.38
1.56
4486.36 *
1259.74
3714.29 *
1042.73
175
11.02
172
14.96

Control treatment in white; altitude treatment in gray. Mean values represented in first
row with the standard deviation below. * = treatment effect ≤ 0.05.
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Simulated Altitude Exposure
Similar to the cyclists’ altitude exposure, only the altitude group’s sleep patterns
were analyzed and demonstrated no significance between days for any parameters.
However, when the cyclists’ (Table 6) and swimmer’s (Table 11) altitude exposure was
analyzed together, an effect for day (p=0.083) was noticed where the quality of sleep
progressively improved each day throughout the exposure (Figure 10).
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Table 11
Swimmer’s simulated altitude exposure

Altitude Exposure
Parameter

Value

O2% In

17.54
2.20

O2% Out

15.36
0.33
61
11.17
59
11.53
9.25
1.10
8.66
1.32
7.58
1.78

HR In
HR Out
Hours Exposure
Hours Sleep
Sleep Quality

Mean values represented in first row with the standard deviation below.
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Figure 10. Altitude exposure sleep quality for cyclists and swimmers. The quality of
sleep was rated on a 1-10 scale, 1 being the worst sleep quality and 10 being the best.
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Chapter V: Discussion
The study design utilized two groups of athletes in order to allow for both the
assessment of MAOD in trained subjects and, in particular, performance in swimmers.
Because of the constraints of the competitive season, it was not possible to do both using
collegiate swimmers. The design was intended to ultimately integrate the two groups at
the completion of the study to analyze the overall effect of the simulated altitude
exposure. Therefore, the discussion section is structured in a way that will highlight the
individual aspects of each study as well as unite the overall findings of the simulated
altitude exposure.
Prior to this study, two research questions were formulated to better understand
the potential relationship between simulated altitude exposure and performance.
1. Can significant physiologic anaerobic improvements, specifically MAOD, and/or
aerobic capacity improvements occur in trained cyclists after a seven day
simulated altitude exposure?
2. Can a short-term, seven-day simulated altitude exposure significantly improve
aerobic capacity and/or race performance in 400-meter swimming trials among
highly trained collegiate swimmers?

The overall findings of the present study demonstrate that there were no
significant adaptations in any parameter measured throughout the seven-day simulated
altitude exposure to 2,500m among trained male cyclists and swimmers. Particular
individuals did demonstrate changes pre- and post-treatment; however, these variables
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were not statistically significant, which led the investigators to conclude that there was no
overall effect of the treatment with regard to either of the research questions.

Performance Results
Cyclists: In the present study there was no significant difference in MMPO4min
between the two groups. However, there was a greater yet non-significant improvement
in power output from Trial 2 to 3 in the altitude compared to the control group.
Swimmers: There were no significant differences between the altitude and control
group regarding the 400-meter swim performance time. Even though the fastest times
occurred during the altitude treatment, the control group non-significantly improved their
performance time from Trial 1 to Trial 2 (Figure 7). It is difficult to state with confidence
what occurred as a result of the altitude exposure regarding swim performances. Seeing
that the control group improved to a greater extent from Trial 1 to Trial 2 eliminates the
explanation of a treatment effect. This also contradicts previous arguments for a placebo
effect (Baker & Hopkins, 1998; Clark, Hopkins, Hawley & Burke, 2000). Although the
control group experienced a greater volume of training (p=0.043) than the altitude group,
the swimmers swam as a team with their coach in the “spring season” to avoid any
confounding factors in their schedule (e.g. competitions, tapers, etc.). This difference in
training volume was a coincidence of the cross-over design. Since the swimmers were
intercollegiate varsity athletes, the level of fitness is consistently high and therefore is
less likely to have been affected by the difference in training volume (Bailey, Davies, &
Baker, 2001; Levine & Stray-Gundersen, 1997).
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Robach and colleagues (2006b) found no significant improvements in swimming
performance after a 13-day LHTL exposure. Results did indicate improvements in red
cell volume and VO2max; however, these did not translate to performance. The exposure
parameters by Robach et al. (2006b) exposed the swimmers to 13 days of LHTL at
2,500m, 3,000m, and 3,500m for 11 hours a day, which was a greater degree of exposure
than in the present study. Based on previous conclusions regarding the optimal approach
to altitude exposure, the approach of Robach et al. (2006b) should have been more likely
to result in performance improvements.
Then again, a variety of researchers have discovered performance improvements
of 1 to 4 percent for events lasting 1 to 15+ minutes after LHTL exposures (Reviewed in
Roberts et al., 2003). According to Hopkins (1999), a 1 percent improvement in
performance time increases the chance of winning an international 1500m running race
by 10 to 20 percent. The time frames to complete the test event are similar between
Hopkins’ and the present study (3:30 vs. 4:30 minutes). Therefore, this level of change
could have a similar impact in the results for the 400-meter in swimming.

Peak Oxygen Consumption (VO2peak)
Cyclists: The results show that the control group’s VO2peak was significantly
higher (p≤0.05) compared to the altitude group. Training was recorded but not
controlled, and consideration for the time of the season was not accounted for when
initiating the testing for this research. Therefore, these factors could have coincidentally
contributed to a greater level of fitness when the participants completed control testing
compared to altitude testing.
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Trial 1 resulted in a lower VO2peak in both the altitude and control groups when
compared to Trials 2 and 3, although non-significant. This difference in VO2peak could
have been a result of the differences in protocol. The warm-up associated with Trials 2
and 3 arguably allowed for a greater ability to initiate aerobic metabolism prior to the
start of the test.
Swimmers: The results indicate that there was not a treatment by trial interaction
regarding VO2peak among the swimmers. However, the altitude group tended (p=0.139;
Table 8) to have a mean VO2peak greater than that of the control group. Conversely, the
control group resulted in a non-significantly greater improvement in VO2peak from Trial 2
to 3 than the altitude group. As previously stated in the discussion of 400-meter
performance trials, regardless of the control group’s greater training volume over the
altitude group, the nature of the team’s consistent conditioning should limit any impact
on fitness improvements.
Several studies have resulted in VO2max improvements (Wehrlin, Zuest, Hallen, &
Marti, 2006; Stray-Gundersen, Chapman, & Levine, 2001). However, each study has a
slightly different protocol design, which could result in significant implications on the
results. Levine and Stray-Gundersen (1997) discovered improvements of 5 percent
(p<0.05) in VO2max. However, this was demonstrated in both the altitude and control
group. Therefore, this adaptation cannot be concluded to be a result of the altitude
treatment. Brugniaux et al. (2006) found VO2max improvements in swimmers and runners
of 8.1 percent (p<0.09) and 7.1 percent (p<0.05), respectively. Opposing this common
view, Gore et al. (1997) discovered no change in VO2max in high-caliber cyclists after a
31 day exposure at 2,650m. This supports the more recently developed thought that
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adaptations in the aerobic energy systems may not be as prominent or important as once
believed, leaving other mechanisms as possible contributors.
Although this was not the result of the present study, many researchers have
discovered a decrease in VO2max after exposure to altitude (Gore et al., 2001; Hahn et al.,
2001). Gore et al. (2001) discovered a 7 percent reduction in VO2max after 23 nights of
LHTL and concluded that there was likely an increase in mechanical efficiency. The
explanation for a reduction in VO2max is not fully understood, but the most common
thought is that the body’s mechanical efficiency is improved or the individual is
experiencing a detraining effect due to constraints and/or alterations in their training
routine (Gore et al., 2001). Furthermore, Hahn et al. (2001) contends that the systemic
delivery of oxygen is redistributed, allowing only a portion of the increased oxygen
carrying capacity to be fully utilized by the exercising muscles.
Much of the previous research involving altitude research has included blood
analysis. Several blood components, such as erythropoietin, red blood cell number and
volume, iron levels, hematocrit, and hemoglobin, are analyzed to evaluate the effect of
altitude. These analyses allow for identification of the underlying mechanisms that
ultimately promote metabolic and performance improvements. However, the resources
for these measurements were unavailable in the present study; therefore, reliance on
previous research was made to provide possible implications of blood adaptations on the
results of this study.
Although there was no overall adaptation found in the present study, the
simulated altitude exposure may have stimulated other physiological parameters that
were not analyzed. Increases in erythropoietin are often believed to be a major
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contributor, and often times the first adaptation necessary, to allow for other physiologic
adaptations (Levine & Stray-Gundersen, 1992, 1997, 2006). Ri-Li et al. (2002)
discovered that erythropoietin increased significantly (24-30 percent, p<0.05) after 6
hours exposure and further increased by approximately 77-92 percent (p<0.05) after 24
hours. Koistinen et al. (2000) measured the erythropoietic effects to a seven-day altitude
exposure to 2,500m. Results demonstrated serum erythropoietin increases of 78 and 71
percent (p<0.05) in both the 24-hour-per-day and 12-hour-per-day groups, respectively.
Similarly, Hahn et al. (2001) discovered significant increases in erythropoietin of 80
percent (p<0.05) after five nights at a moderate altitude exposure. However, this increase
in erythropoietin was not enough to stimulate erythrocyte production. In agreement,
Ashenden et al. (2000) found significant (p<0.01) increases in erythropoietin levels in the
altitude exposed group but not in the control group. Regardless of this increase,
reticulocyte production was not affected at any point. This exemplifies that an increase
in erythropoiesis does not always result in improvements in red cell volume, VO2max, or
performance. These findings relate well to the present study due to the similarities in
exposure parameters. Therefore, one could postulate that the participants in the present
study may have adapted in a similar fashion; however, blood analysis was not performed
in order to realize these adaptations. Regardless, the participants in the present study did
not demonstrate improvements in the measured parameters, thereby suggesting that any
improvements in EPO after a seven-day altitude exposure are not capable of eliciting
aerobic and/or anaerobic capacity improvements.
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Maximal Accumulated Oxygen Deficit
Cyclists: In the present study, no significant difference was found in MAOD
between the altitude and control groups. However, pre- to post-treatment results
demonstrated a greater yet non-significant increase in MAOD among the altitude group
than the control group (Figure 6).
The postulation of anaerobic improvements as a result of altitude exposure is a
fairly new topic of research. Roberts and colleagues (2003) used very similar altitude
exposure parameters in their study design and found significant adaptations in MMPO4min
(3.7 percent, p<0.05), MAOD (9.6 percent, p<0.05), and VO2max (p<0.05). In fact, the
present study was designed in some regards after Roberts et al. (2003) in order to
investigate potential anaerobic and performance adaptations to a short-term altitude
exposure. The results obtained in the present study, which presented no significant
values in MAOD or VO2peak, conflict with the results found by the Roberts team. Roberts
et al. (2003) looked at changes in MAOD after altitude exposure of 5, 10, and 15 days.
There was no difference in the MAOD adaptation between the varying lengths of
exposure. However, when the exposure durations were analyzed as a group, significant
improvement in MAOD was observed. Further, in the group analysis, there was no
significant difference between the individual exposure durations. The lack of significant
MAOD improvement (p=0.730) in the present study’s 7-day exposure conflicts with
Roberts and colleague’s (2003) finding of significant MAOD (p<0.05) adaptation after 5
days of exposure. Therefore, it is speculated that the combination of all three exposure
groups may have strengthened the overall power by improving a potentially weak power
in the 5-day exposure.
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Mizuno et al. (1990) found a 29 percent (p<0.05) improvement in MAOD as well
as short-term running performance (p<0.05) among runners after altitude exposure. This
performance improvement occurred even though VO2max was unchanged. Furthermore,
muscle biopsies of the gastrocnemius and triceps brachii demonstrated a 6 percent
improvement in muscle buffer capacity (p<0.05). Seeing as there was no improvement in
VO2max, the improvement in performance likely resulted from a greater anaerobic
capacity as a result of the LHTL exposure. In another study, Hahn et al. (2001) found
that athletes were able to produce more work per liter of oxygen consumed after altitude
exposure, possibly concluding that performance benefits are likely the result of increased
anaerobic capacity or a greater efficiency of aerobic metabolism. There were no
significant changes in cyclist’s VO2peak or power output in the present study. However,
the altitude group demonstrated a non-significantly greater improvement in power output
from Trial 2 to 3 than the control group. Gore et al. (2001) discovered a decrease in
VO2peak after LHTL exposure but no significant change in the work performed throughout
the cycle ergometer testing. Furthermore, muscle buffer capacity increased significantly
in the LHTL group (p<0.05) but was unchanged in the control. Therefore, had the
subject number been higher in the present study, similar adaptations may have
demonstrated a greater level of significance.
Contrary to the previous research, Levine and Stray-Gundersen (2006), who have
completed several altitude related research studies (Levine, 2002; Levine & StrayGundersen, 1992; Levine & Stray-Gundersen, 1997), adamantly state that they have
never seen an improvement in MAOD, buffer capacity, or running economy. Similar
techniques to realize these measures were used over the course of 10 years with more
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than 100 athletes. The primary focus for these researchers surrounds aerobic adaptations;
therefore, little discussion occurred regarding this discrepancy.

Blood Lactate Concentration
Cyclists: In the present study there were no significant changes in blood lactate
concentration under resting or post exercise conditions, although there was a trend for
treatment by trial interaction (p=0.12) in the control group, whose resting lactate
concentration decreased from Trial 2 to 3 to a greater extent than the altitude group.
Swimmers: There were no significant differences found between resting or postlactate concentrations in either group while performing the laboratory tests. However,
the altitude group demonstrated a non-significant gradual decline in resting lactate values
over the course of the three trials.
There were no significant differences during the 400-meter performance trials in
resting or post-lactate concentrations between the altitude and control groups.
Nummela and Rusko (2000) analyzed sprinters and discovered a significant
improvement in 400-meter running performance time (.8 percent, p<0.01), as well as
running speed at given lactate concentrations after a 10-day exposure to 2,200m.
Therefore, it was concluded that the adaptation was an improvement in anaerobic
capacity. Additionally, Clark et al. (2004) performed a simulated altitude exposure
protocol very similar to the present study; however, the length of exposure was 20 days.
Lactate kinetics were significantly altered (p<0.05) after the continuous LHTL exposure,
which was demonstrated by decreased plasma lactate concentrations at 85 percent VO2max
as well as an increase in workload at 4 mmol/L lactate. However, there was no difference
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between any group in regard to muscle buffer capacity or MCT1 and MCT4 abundance.
This is possibly due to the belief that the lactate/H+ transport system is more active
during activity compared to rest, so altitude exposure during resting conditions may not
be appropriate to elicit alterations (Juel, Lundby, Sander, Calbert & Hall, 2003).
Therefore, this could have contributed to the lack of significant difference in lactate
values throughout the simulated altitude exposure.
Participants in a LHTL exposure by Gore et al. (2001) demonstrated a significant
7 percent reduction in VO2peak, whereas the control group experienced no change. This
occurred without any significant change in the work performed throughout the cycle
ergometer testing. Furthermore, muscle buffer capacity increased significantly in the
LHTL group but was unchanged in the control. Finally, blood lactate levels did not
increase significantly due to the LHTL exposure, although values were significantly
different between the LHTL and control groups pre- and post-exposure. However, the
present study’s lack of significant increase in post-lactate concentration and performance
improvement after maximal exercise and LHTL exposure likely indicate no improvement
in muscle buffer capacity.

Power Output
Swimmers: The altitude group was able to produce a greater amount of power
(p=0.058) than the control group. Furthermore, a trend for a treatment by trial interaction
(p=0.112) is visible with regard to the improvement in power production from Trial 2 to
3 by the altitude group when compared to the same parameters in the control group.
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Time to Exhaustion
Swimmers: The altitude group completed the arm ergometer test protocols longer,
therefore resulting in a trend for a treatment by trial interaction (p=0.193) and treatment
effect (p=0.114).
Without a significant increase in VO2peak or lactate values, it is difficult to
speculate why these trends occurred.

Responders VS. Non-responders
As athletes and coaches continue to incorporate altitude training into their
seasonal plan, many want to know if any adaptation to the exposure is likely to occur.
Some have postulated that one’s ability to adapt to altitude is dependent on appropriate
iron levels (Levine, 2002; Baker & Hopkins, 1998). According to Baker and Hopkins
(1998), adequate iron levels allow for red blood cell improvement, which may ultimately
promote an improvement in performance. Chapman, Levine, and Stray-Gundersen
(1998) categorized participants as either responders or non-responders based on some
participants’ inability to demonstrate an adaptation to the altitude exposure, whereas
others demonstrated significant adaptations (as introduced in the Literature Review
section). Therefore, Chapman et al. (1998) classified participants based on their ability to
express a series of acclimatization response increases in erythropoietin, red cell volume,
VO2max, and ultimately performance time.
At this point, it is difficult to predict an individual’s response to altitude exposure.
There are numerous combinations to the exposure, training, and physiological parameters
that ultimately contribute to the classification of “responder” or “non-responder.” Even
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still, the magnitude of response is no guarantee. Therefore, Wilber, Stray-Gundersen,
and Levine (2007) conclude that there is an inability to identify exactly why
individualized responses to altitude exposure exist.

Limitations
The modalities used to complete the laboratory testing sessions were performed
on sport-specific equipment. The Velotron was appropriately fit for each cyclist in order
to replicate the geometry of their personal bicycle. This ensured that participants were
comfortable and able to produce optimal results during the testing sessions. However,
many of the swimmers using the arm ergometer suffered from forearm and hand fatigue
during the tests. Subjects were encouraged to change hand positions throughout the test,
although all grips ultimately required the musculature of the forearms to a greater extent
than many were accustomed to. However, due to the lack of significant difference in
power output between Trials 1, 2, and 3, this was not a factor in the present study. A
recommendation for future investigators using an arm ergometer is to develop a strap
system for the hands so the participant’s arms can be safely and effectively fixed to the
ergometer without requiring the subject to constantly grip the handles of the ergometer.
This may more effectively allow the participant to exhaust the cardiorespiratory system
instead of the forearm musculature affecting the test.
Due to the altitude exposure timeline being strictly set at seven days, all testing
surrounding this timeline was extremely sensitive. In order to maintain optimal accuracy,
reproducibility, and reliability of the laboratory tests, the test schedule was to be
replicated for each participant. As mentioned in the results section, there were a few
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unavoidable circumstances that necessitated altering of this schedule. One subject
became ill with an upper respiratory tract infection, requiring the final trial of the control
round to be delayed by four days. It is possible that this deviation in protocol could have
impacted the participant’s performance. Another individual was physically assaulted
before he could complete his control round testing, and therefore that participant’s
control data were discarded. This study incurred tight time constraints, which
exacerbated many of these issues. Individuals interested in embarking on a similar study
should create a timeline that allows for equipment malfunctions and/or participants’
unexpected inability to test on a scheduled day.
The participants in this study reported that they had an overall positive experience
while using the altitude tents. A common comment by many researchers is that
participants experience altitude sickness (Roeggla, Roeggla, Podolsky, Wagner, &
Laggner, 1996). This was not the case for any participants in this study, indicating that
2,500m was an appropriate level of simulated altitude. Alternatively, the stimulus may
have been insufficient because no participants resulted in significant performance
improvements or altitude sickness. Some made comments that they felt more energized
during workouts and laboratory sessions, and recovered more quickly after workouts.
However, several participants complained about the quality of sleep during their
simulated altitude exposure, largely a result of the hot and stuffy environment inside the
tent. Additionally, four participants stated they had unusual nightmares on more than one
occasion while in the altitude tent. Figure 10 demonstrated a significant daily
improvement (p=0.05) in sleep quality as the seven-day exposure progressed. Due to the
fact that the control group did not record quality of sleep it is difficult to speculate, but it
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is possible that the poor quality of sleep in the first few nights could have negatively
impacted the participant’s ability to perform on subsequent testing days. As athletes
prepare for competition, sleep is regarded as an important component in that preparation
(Samuels, 2008). Therefore, if a participant’s sleep quality in the present study was
jeopardized, that could provide a rational explanation, at least in part, for an inability to
improve performance.

Direction of Future Research
Future research should further investigate the potential physiologic adaptations to
both (a) short term altitude exposures and (b) anaerobic capacity improvements. Roberts
et al. (2003) were able to identify significant improvements in MAOD using an altitude
exposure for as little as 5 days. The potential for anaerobic capacity improvements
elicited from altitude exposure could revolutionize sport; however, it may take a longer
exposure to result in the necessary adaptations. The present study was not able to analyze
changes in blood parameters to the seven-day exposure; however, future studies could
investigate the potential impact on performance. The main focus should be to discover
the exposure parameters necessary to result in optimal anaerobic and aerobic
performance improvements, understanding that these two likely require a different
exposure structure.

Conclusion
It has been demonstrated in much of the previous research that exposure to
altitude can result in physiologic and performance adaptations (Gore et al., 2001; Levine
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& Stray-Gundersen, 1997, 2001; Roberts et al., 2003; Wilber, 2001). There are many
likely explanations for the lack of significant adaptations in our participants. First of all,
one of the novel aspects to our approach was the short term (7-day) exposure. To
reiterate, much of the literature strongly states a minimum of 14 days is needed to allow
for adaptations. Therefore, it is possible that participants were not given adequate time to
initiate the necessary adaptations that would be visible in our laboratory measures.
Secondly, the length of daily exposure may have also been too short. Again, previous
studies suggest 12-16 hours of exposure per day, whereas our participants were instructed
to occupy the tent for 8-12 hours per day. Saying this, the average daily exposure by our
participants was actually 8.5 hours per day. Therefore, the participants in this study may
have needed to occupy the altitude tent for a greater duration each day.
The overall findings of this research conclude that there were no significant
adaptations in MAOD, VO2peak, or performance among highly trained cyclists and
swimmers after a 7-day simulated altitude exposure. There were, however, interesting
trends that call for further investigation. Previous research has demonstrated that altitude
exposure has the potential to result in physiologic adaptations; however, appropriate
levels of elevation and duration to the altitude exposure must be achieved to elicit these
improvements. Therefore, it is the conclusion of this study that a 7-day simulated altitude
exposure to 2,500m for 8.5 hours each night is insufficient of resulting in MAOD,
VO2peak, or performance improvements among highly trained cyclists and swimmers.
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Cyclists Informed Consent
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Eastern Michigan University
Applied Physiology Laboratory
Informed Consent for Research Involving Human Subjects
Title of Project:
Adaptations in Maximal Accumulated Oxygen Deficit (MAOD) after a "Living HighTraining Low" approach using simulated altitude exposure
Principal Investigator:

Ian Ratz

Co-Principal Investigator:

Stephen J. McGregor, Ph.D.
318 Porter Building
(734) 487-7120 ext. 2726

Methods: You have been invited to participate in a study examining the effects of
simulated altitude exposure on anaerobic performance adaptations. You must be a
recreationally trained individual (minimum of 8 hours/week) and range in age from 18 to
45 years. All participants will be required to provide medical clearance for maximal
exercise and simulated altitude exposure. If you have been exposed to an altitude greater
than 2000m for longer than 14 days in the past 3 months, you may be excluded from the
study.
On seven separate occasions, you will be asked to come to the Exercise Physiology
Laboratory at Eastern Michigan University. Your first two testing sessions will consist of
a Maximal Mean Power Output in 4 minutes (MMPO4min) test, where your power output
and maximal oxygen uptake (VO2max) will be measured over a 4 minute all out effort on a
Velotron cycle ergometer. These are accepted measures of an individual’s aerobic
capacity and will be used to determine workloads for subsequent tests. Blood lactates
will be analyzed immediately after the MMPO4min test. This will consist of either an
earlobe or finger prick to draw a small blood sample.
The remaining testing sessions are identical and will measure your anaerobic capacity.
This will be achieved by following a Maximal Accumulated Oxygen Deficit (MAOD)
protocol on a Velotron cycle ergometer. You will first complete a 4-minute warm up at
50 W. This will be followed by an incremental test with three intervals lasting 6 minutes
each at 50%, 62.5%, and 75% of MMPO4min. After each 6-minute interval a 4-minute
rest will take place, consisting of 2 minutes active rest at 50 W followed by 2 minutes
seated passive rest. After the final 4-minute resting period, the same MMPO4min test will
be administered. Blood lactates will be analyzed immediately after the MAOD test. This
will consist of either an earlobe or finger prick to draw a small blood sample.
During these sessions a Jaeger Oxycon Metabolic Cart will be utilized to collect expired
gases. This consists of a facemask attached to a very small unit worn on your body
during exercise. This device measures the oxygen and carbon dioxide gases that you
inhale and exhale to give the physiologists the data we need to determine aerobic capacity
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and other important information that will be shared with you at the end of the study.
Your heart rate will be monitored with a Polar heart rate monitor.
You will be asked to adhere to several restrictions prior to performing each of the
laboratory testing sessions. Your workouts the day before testing should be light and
easy. You will need to reside in the altitude tent by yourself (sleeping or awake) for 8-12
hours/day for a period of 7 days. The principle investigator will setup the tent at your
home and will explain its operation before use. You will need a responsible adult in your
home to supervise your well being during the simulated altitude exposures. You will be
asked to keep a logbook including daily recordings of workout distance, intensity/pace,
modality of training, and max heart rate (HR). It should also include information about
the tent such as hours spent in tent each night, hours of sleep, quality of sleep, resting
HR, and verification of the O2 percentage inside the tent. Any additional comments you
feel necessary should be written in the logbook. Finally, you are requested to refrain
from the consumption of alcohol 24 hours before a testing session and caffeine
consumption the day of a testing session. Also, do not eat anything 2 hours prior to
testing.
Benefits: There is no monetary compensation for participating in this study. You will
benefit by learning your aerobic fitness level (MMPO4min), anaerobic work capacity
(MAOD test), and your response to simulated altitude exposure. Your performance could
potentially improve due to the simulated altitude exposure. The simulated altitude
exposure could potentially negatively impact performance if the recommended guidelines
are not followed (ie: oxygen concentration too low).
Potential Risks: Individuals may experience symptoms of altitude sickness, which may
include: headache, lack of appetite, nausea, vomiting, fatigue, weakness, dizziness, lightheadedness, and insomnia. The manufacturer of the tent, Hypoxico, has determined the
tent to be “just as safe as flying in a commercial plane”. Participants will be exposed to
an altitude that is between Denver, CO (1609 m) and Breckenridge, CO (2926 m).
Equipment Responsibility: It is expected that you will take care of the Simulated
Altitude Training System while it is in your posession. The principle investigator will set
up the system in your home and give thorough instruction of its use. Adherence to these
instructions should prevent damage to the system. If, however, the Simulated Altitude
Training System is damaged during your possession that is not attributed to a “normal
malfunction”, you are to be held responsible for this damage. This damage includes, but
is not limited to: carelessness, neglecting the operating instructions given by the Principle
Investigator, overheating of the generator due to improper location of the generator,
ripping/tearing of the tent material, damage to the oxygen sensors, etc.
Therefore, please lock your doors and make sure you are the only person using
the Simulated Altitude Training System. If at any point while the tent is your possession
and malfunction or damage to the system is to occur, you are to call the principle
investigator directly at (952) 210-3003.
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It is important for you to understand that at any time, you may withdraw from the study
without prejudice or effect on your relationship to Eastern Michigan University.
All of the results from this study will be kept confidential. If publication occurs, only
numbers will be used, not names. Throughout the study, some of the data obtained from
your participation will be made available to you. At the conclusion of the study, any
additional data obtained from your participation will be made available to you. Any
concerns with regard to approval or research procedures should be directed to the Eastern
Michigan University College of Health and Human Services Human Subjects Review
Committee. The Chairperson of the committee may be contacted at (734) 487-1238.

I,________________________________, hereby give my consent to participate in the
research study entitled “Anaerobic and performance adaptations to a "Living HighTraining Low" approach using simulated altitude exposure.” The details of which have
been provided to me, including anticipated benefits, risks, and potential complications. I
also understand the operation of the Simulated Altitude Training System and agree to
take responsibility for any unnecessary damage to the system.
I fully understand that I may withdraw from this research project at any time without
prejudice or effect on my standing with Eastern Michigan University. I also understand
that I am free to ask questions about any techniques to be used or procedures to be
undertaken.
I understand that in the unlikely event of a physical injury resulting from research
procedures that medical treatment will be arranged but the costs of the treatment will be
my responsibility since Eastern Michigan University will not provide financial
compensation.
Finally, I understand that the information about me that is obtained during the course of
this study will be kept confidential unless I consent to its release.
_________________________________

_______________

Participant’s signature

Date

I hereby certify that I have given an explanation to the above individual of the
contemplated study and its risks and potential complications.
_________________________________

________________

Principal Investigator

Date
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APPENDIX B

Swimmers Informed Consent
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Eastern Michigan University
Applied Physiology Laboratory
Informed Consent for Research Involving Human Subjects
Title of Project:
Aerobic and performance adaptations to a "Living High-Training Low"
approach using simulated altitude exposure
Principal Investigator:

Ian Ratz

Co-Principal Investigator:

Stephen J. McGregor, Ph.D.
318 Porter Building
(734) 487-7120 ext. 2726

Methods: You have been invited to participate in a study examining the effects of
simulated altitude exposure on aerobic capacity as well as performance adaptations. You
must be a trained swimmer from Eastern Michigan University’s Swim Team, University
of Michigan’s Swim Team, Club Wolverine, or part of the local masters team and range
in age from 18 to 45 years. If you have been exposed to an altitude greater than 2,000m
for longer than 14 days in the past 3 months, you may be excluded from the study.
On five separate occasions, you will be asked to come to the campus of Eastern Michigan
University. Swimming trials will occur in the Jones Natatorium and laboratory testing
will occur in Warner 109. University of Michigan testing will occur at Canham
Natatorium. You will perform five tests that will elicit peak oxygen consumption
(VO2peak) on a SciFit arm ergometer. This will require you to perform an incremental
protocol starting at 50 Watts and ending with volitional exhaustion. This test will result
in your VO2peak and Peak Power Output (PPO), which are accepted measures of an
individual’s aerobic capacity. During a portion of the study, you will serve as the
treatment group when you will undergo a seven-day period of simulated altitude exposure
at 2,500m. Blood lactates will be analyzed pre- and post-test. This will consist of either
an earlobe or finger prick to draw a small blood sample.
During these sessions a Jaeger Oxycon Metabolic Cart will be utilized to collect expired
gases. This consists of a facemask attached to a very small unit worn on your body
during exercise. This device measures the oxygen and carbon dioxide gases that you
inhale and exhale to give the physiologists the data we need to determine aerobic capacity
and other important information that will be shared with you at the end of the study.
Your heart rate will be monitored with a Polar heart rate monitor.
You will complete a swimming trial one time each week throughout the study. This will
require you to swim a timed 400 meter freestyle swim at your maximal ability as part of
your training sessions. Blood lactate concentrations will be analyzed pre- and post-test in
the same manner described previously.

104

You will be asked to adhere to several restrictions prior to performing each of the
laboratory testing sessions. Your workouts the day before testing should be light and
easy. Your coach is aware of this restriction. You will need to reside in the altitude tent
by yourself (sleeping or awake) for 8-12 hours/day for a period of 7 days. The principle
investigator will setup the tent at your home and will explain its operation before use.
You will need a responsible adult in your home to supervise your well being during the
simulated altitude exposures. You will be asked to keep a logbook including daily
recordings of workout distance, intensity/pace, modality of training, and max heart rate
(HR). It should also include information about the tent, such as hours spent in tent each
night, hours of sleep, quality of sleep, resting HR, and verification of the O2 percentage
inside the tent. Any additional comments you feel necessary should be written in the
logbook. Finally, you are requested to refrain from the consumption of alcohol 24 hours
before a testing session and caffeine consumption the day of a testing session. Also, do
not eat anything 2 hours prior to testing.
Benefits: There is no monetary compensation for participating in this study. You will
benefit by learning your aerobic fitness level (VO2peak) and your response to simulated
altitude exposure. Your swimming performance could potentially improve due to the
simulated altitude exposure. The simulated altitude exposure could potentially negatively
impact performance if the recommended guidelines are not followed (ie: oxygen
concentration too low).
Potential Risks: Individuals may experience symptoms of altitude sickness, which may
include: headache, lack of appetite, nausea, vomiting, fatigue, weakness, dizziness, lightheadedness, and insomnia. The manufacturer of the tent, Hypoxico, has determined the
tent to be “just as safe as flying in a commercial plane”. Participants will be exposed to
an altitude that is between Denver, CO (1609 m) and Breckenridge, CO (2926 m).
Equipment Responsibility: It is expected that you will take care of the Simulated
Altitude Training System while it is in your posession. The principle investigator will set
up the system in your home and give thorough instruction of its use. Adherence to these
instructions should prevent damage to the system. If, however, the Simulated Altitude
Training System is damaged during your possession that is not attributed to a “normal
malfunction”, you are to be held responsible for this damage. This damage includes, but
is not limited to: carelessness, neglecting the operating instructions given by the Principle
Investigator, overheating of the generator due to improper placement of the generator,
ripping/tearing of the tent material, damage to the oxygen sensors, etc.
Therefore, please lock your doors and make sure you are the only person using
the Simulated Altitude Training System. If at any point while the tent is your possession
and malfunction or damage to the system is to occur, you are to call the principle
investigator directly at (952) 210-3003.
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It is important for you to understand that at any time, you may withdraw from the study
without prejudice or effect on your relationship to Eastern Michigan University.
All of the results from this study will be kept confidential. If publication occurs, only
numbers will be used, not names. Throughout the study, some of the data obtained from
your participation will be made available to you. At the conclusion of the study, any
additional data obtained from your participation will be made available to you. Any
concerns with regard to approval or research procedures should be directed to the Eastern
Michigan University College of Health and Human Services Human Subjects Review
Committee. The Chairperson of the committee may be contacted at (734) 487-1238.
I,________________________________, hereby give my consent to participate in the
research study entitled “Aerobic and performance adaptations to a "Living High-Training
Low" approach using simulated altitude exposure.” The details of which have been
provided to me, including anticipated benefits, risks, and potential complications. I also
understand the operation of the Simulated Altitude Training System and agree to take
responsibility for any unnecessary damage to the system.
I fully understand that I may withdraw from this research project at any time without
prejudice or effect on my standing with Eastern Michigan University. I also understand
that I am free to ask questions about any techniques to be used or procedures to be
undertaken.
I understand that in the unlikely event of a physical injury resulting from research
procedures that medical treatment will be arranged but the costs of the treatment will be
my responsibility since Eastern Michigan University will not provide financial
compensation.
Finally, I understand that the information about me that is obtained during the course of
this study will be kept confidential unless I consent to its release.

_________________________________

_______________

Participant’s signature

Date

I hereby certify that I have given an explanation to the above individual of the
contemplated study and its risks and potential complications.
_________________________________

________________

Principal Investigator

Date
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APPENDIX C
Altitude Tent Exposure Supervisor Informed Consent
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Eastern Michigan University
Applied Physiology Laboratory
Informed Consent for Research Involving Human Subjects
Title of Project:
Aerobic and performance adaptations to a "Living High-Training Low"
approach using simulated altitude exposure
Principal Investigator:

Ian Ratz

Co-Principal Investigator:

Stephen J. McGregor, Ph.D.
318 Porter Building
(734) 487-7120 ext. 2726

As a safety precaution during the “Aerobic and performance adaptations to a "Living
High-Training Low" approach using simulated altitude exposure” study, it is requested
that you provide supervision to the participant. This requires that you will be in the same
residence as the participant throughout the 7-day duration of the simulated altitude
exposure.
I understand that my responsibilities include, but are not limited to:
1) Verifying that the oxygen concentration is at the recommended setting before the
participant enters the simulated altitude tent.
2) Checking on the participant periodically to ensure their safety.
3) Checking for signs of altitude sickness:
a. Headache (generally in combination with one or more of the below
symptoms)
b. Lack of appetite, nausea, or vomiting
c. Fatigue or weakness
d. Dizziness or light-headedness
e. Insomnia
4) Calling the Principle Investigator if there are any equipment malfunctions.
5) Calling 911 in the event of an emergency.
I also understand that it is the participant’s decision to participate in this study and I am
volunteering as an extra safety precaution. The participant is aware of the protocol and of
any potential risks and benefits.
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I,________________________________, hereby agree to provide responsible adult
supervision for _____________________________ while he is residing in the Hypoxico
Altitude Tent provided for the purposes of the “Aerobic and performance adaptations to a
"Living High-Training Low" approach using simulated altitude exposure” study. I will
be in the same residence as the participant throughout the 7-day duration of the simulated
altitude exposure. I am aware of my responsibilities during the participant’s exposure.

I fully understand that I may withdraw from this research project at any time without
prejudice or effect on my standing with Eastern Michigan University. I also understand
that I am free to ask questions about any techniques to be used or procedures to be
undertaken.

_________________________________

________________

Supervisor’s signature

Date

I hereby certify that I have given an explanation to the above individual of the
contemplated study and its risks and potential complications.
_________________________________

________________

Principal Investigator

Date
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APPENDIX D
Cyclists Logbook
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Altitude Exposure Logbook
Name:

Please complete this logbook everyday and provide as much detail as possible. This will
allow the researcher to better analyze the results and understand your individual
experience in the simulated altitude tent.
Definitions of Terms:
AM & PM Workout
Type: type of workout? (e.g. group ride, endurance, intervals, sprints, strength, etc.)
Difficulty: 1 is considered the “easiest” workout, 5 is an “average” workout, 10 is
considered the “hardest” workout.
Distance: total miles in that workout session.
Duration: length of workout session (in hours).
Power: If available, record average power and kilojoules for each workout session.
Max HR: maximum heart rate during your workout session for that day
Notes: please provide any additional notes you deem necessary, appropriate, or helpful.
Entering Tent
Time on: the time that you turned the generator’s power on.
Time in: the time that you entered the tent.
O2%: the oxygen concentration value inside the tent upon entering.
Resting HR: your heart rate while resting and relaxed.
Alcohol?: Did you consume alcohol today? If so, what type, in what quantity, and when
did you finish drinking?
Exiting Tent
O2%: the oxygen concentration value inside the tent upon exiting.
Resting HR: your heart rate while resting and relaxed.
Time out: the time that you exit the tent.
Hours of sleep: the number of hours you slept while inside the tent.
Sleep quality: 1 would be the “worst” nights sleep, 5 would be an “average” nights sleep,
10 would be the “best” nights sleep. Please explain …
Daily Notes: please provide any additional notes you deem necessary, appropriate, or
helpful. This could include things such as extra alertness, increased fatigue, headache,
more stamina, better endurance, shortness of breath, feelings of discomfort, irritability,
anxiousness, extra energy, increased mood, etc.
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DAY #1

Date:

AM Workout
Type:
Difficulty (1-10):
Distance:
Duration:
Power:
Max HR:
Notes:

PM Workout
Type:
Difficulty (1-10):
Distance:
Duration:
Power:
Max HR:
Notes:

Entering Tent
Time on:
Time in:
O2 %:
Resting HR:
Alcohol?
Exiting Tent
O2 %:
Resting HR:
Time out:
Hours of sleep:
Sleep Quality (1-10):

Daily Notes:
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APPENDIX E
Swimmers Logbook
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Altitude Exposure Logbook
Name:

Please complete this logbook everyday and provide as much detail as possible. This will
allow the researcher to better analyze the results and understand your individual
experience in the simulated altitude tent.
Definitions of Terms:
AM & PM Practices/Workouts
Type: what type of practice was it? (e.g. sprint, distance, kicking, pulling, stroke, etc)
Difficulty: 1 is considered the “easiest” practice, 5 is an “average” practice, 10 is
considered the “hardest” practice.
Distance: total meters swam during that day’s practice session.
Duration: length of time that practice lasted.
Max HR: maximum heart rate during your practice session for that day
Notes: please provide any additional notes you deem necessary, appropriate, or helpful.
Entering Tent
Time on: the time that you turned the generator’s power on.
Time in: the time that you entered the tent.
O2%: the oxygen concentration value inside the tent upon entering.
Resting HR: your heart rate while resting and relaxed.
Alcohol?: Did you consume alcohol today? If so, what type, in what quantity, and when
did you finish drinking?
Exiting Tent
O2%: the oxygen concentration value inside the tent upon exiting.
Resting HR: your heart rate while resting and relaxed.
Time out: the time that you exit the tent.
Hours of sleep: the number of hours you slept while inside the tent.
Sleep quality: 1 would be the “worst” nights sleep, 5 would be an “average” nights sleep,
10 would be the “best” nights sleep. Please explain …
Daily Notes: please provide any additional notes you deem necessary, appropriate, or
helpful. This could include things such as extra alertness, increased fatigue, headache,
more stamina, better endurance, shortness of breath, feelings of discomfort, irritability,
anxiousness, extra energy, increased mood, etc.
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DAY #1

Date:

AM Practice
Type:
Difficulty (1-10):
Distance:
Duration:
Max HR:
Notes:

PM Practice
Type:
Difficulty (1-10):
Distance:
Duration:
Max HR:
Notes:

Entering Tent
Time on:
Time in:
O2 %:
Resting HR:
Alcohol?
Exiting Tent
O2 %:
Resting HR:
Time out:
Hours of sleep:
Sleep Quality (1-10):

Daily Notes:
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APPENDIX F
Human Subject Approval Form
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#############
@@@@@@@@@@@@@
#############
@@@@@@@@@@@@@
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APPENDIX G
Manufacturer’s Oxygen Equivalents
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Enter genuine altitude in feet in red square, and sea-level pressure in green
square. Go down yellow column to observed oxygen content (calibrate at 20.9
outside hypoxic environment), read off effective oxygen content and effective
altitudes, and also partial pressure of oxygen.
Units for the Partial pressure
column is the SAME as you use for the pressure in the green box.
Enter Location Height in
feet
Location Height in Meters
pressure factor compared with sea level

Monitor
reading
20.9
20.7
20.5
20.3
20.1
19.9
19.7
19.5
19.3
19.1
18.9
18.7
18.5
18.3
18.1
17.9
17.7
17.5
17.3
17.1
16.9
16.7
16.5
16.3
16.1
15.9
15.7
15.5
15.3
15.1
14.9
14.7
14.5
14.3
14.1
13.9

Enter Sea level pressure 760

850
259
0.970

effective
Effective Partial
Oxygen Effective H
H in
pressure
%
in Feet
meters Oxygen
20.26
850
260
154.0
20.07
1,110
340
152.5
19.88
1,380
420
151.1
19.68
1,650
500
149.6
19.49
1,920
580
148.1
19.29
2,190
670
146.6
19.10
2,470
750
145.2
18.91
2,740
840
143.7
18.71
3,020
920
142.2
18.52
3,300
1,010
140.7
18.32
3,590
1,090
139.3
18.13
3,880
1,180
137.8
17.94
4,160
1,270
136.3
17.74
4,460
1,360
134.8
17.55
4,750
1,450
133.4
17.36
5,050
1,540
131.9
17.16
5,350
1,630
130.4
16.97
5,650
1,720
129.0
16.77
5,950
1,810
127.5
16.58
6,260
1,910
126.0
16.39
6,570
2,000
124.5
16.19
6,890
2,100
123.1
16.00
7,210
2,200
121.6
15.80
7,530
2,290
120.1
15.61
7,850
2,390
118.6
15.42
8,180
2,490
117.2
15.22
8,510
2,590
115.7
15.03
8,840
2,690
114.2
14.83
9,180
2,800
112.7
14.64
9,520
2,900
111.3
14.45
9,860
3,010
109.8
14.25
10,210
3,110
108.3
14.06
10,560
3,220
106.8
13.86
10,920
3,330
105.4
13.67
11,280
3,440
103.9
13.48
11,640
3,550
102.4

effective
Effective Partial
Monitor Oxygen Effective
H in
pressure
%
H in Feet meters Oxygen
reading
13.7
13.28
12,010
3,660
101.0
13.5
13.09
12,380
3,770
99.5
13.3
12.90
12,760
3,890
98.0
13.1
12.70
13,140
4,010
96.5
12.9
12.51
13,530
4,120
95.1
12.7
12.31
13,920
4,240
93.6
12.5
12.12
14,310
4,360
92.1
12.3
11.93
14,720
4,490
90.6
12.1
11.73
15,120
4,610
89.2
11.9
11.54
15,540
4,740
87.7
11.7
11.34
15,950
4,860
86.2
11.5
11.15
16,380
4,990
84.7
11.3
10.96
16,810
5,120
83.3
11.1
10.76
17,240
5,260
81.8
10.9
10.57
17,690
5,390
80.3
10.7
10.37
18,130
5,530
78.8
10.5
10.18
18,590
5,670
77.4
10.3
9.99
19,050
5,810
75.9
10.1
9.79
19,520
5,950
74.4
9.9
9.60
20,000
6,100
72.9
9.7
9.40
20,490
6,240
71.5
9.5
9.21
20,980
6,400
70.0
9.3
9.02
21,480
6,550
68.5
9.1
8.82
22,000
6,700
67.1
8.9
8.63
22,520
6,860
65.6
8.7
8.44
23,050
7,020
64.1
8.5
8.24
23,590
7,190
62.6
8.3
8.05
24,140
7,360
61.2
8.1
7.85
24,700
7,530
59.7
7.9
7.66
25,270
7,700
58.2
7.7
7.47
25,860
7,880
56.7
7.5
7.27
26,450
8,060
55.3
7.3
7.08
27,060
8,250
53.8
7.1
6.88
27,690
8,440
52.3
6.9
6.69
28,320
8,630
50.8
6.7
6.50
28,980
8,830
49.4
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